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ABSTRACT
In modern multiple omics high-throughput data analysis, data integration and missing-
ness data handling are common problems in discovering regulatory mechanisms associated
with complex diseases and boosting power and accuracy. Moreover, in genotyping problem,
the integration of linkage disequilibrium (LD) and identity-by-descent (IBD) information be-
comes essential to reach universal superior performance. In pathway analysis, when multiple
studies of different conditions are jointly analyzed, simultaneous discovery of differential and
consensual pathways is valuable for knowledge discovery. This dissertation focuses on the
development of a Bayesian multi-omics data integration model with missingness handling,
a novel genotype imputation method incorporating both LD and IBD information, and a
comparative pathway analysis integration method.
In the first paper of this dissertation, inspired by the popular Integrative Bayesian Anal-
ysis of Genomics data (iBAG), we propose a full Bayesian model that allows incorporation
of samples with missing omics data as well as a self-learning cross-validation (CV) decision
scheme. Simulations and a real application on child asthma dataset demonstrate superior
performance of the CV decision scheme when various types of missing mechanisms are eval-
uated.
In the second paper, we propose a genotype inference method, namely LDIV, to integrate
both LD and IBD information. Both simulation study with different family structures and
real data results showed that LDIV greatly increases the genotype accuracy, especially when
family structures are informative.
v
The third paper presents a meta-analytic integration tool, Comparative Pathway Inte-
grator (CPI), to discover consensual and differential enrichment patterns, reduce pathway
redundancy, and assist explanation of the pathway clusters with novel text mining algo-
rithm. We applied CPI to jointly analyze six psychiatric disorder transcriptomic studies to
demonstrate its effectiveness, and found functions confirmed by previous biological studies
and new enrichment patterns.
All three projects could have substantial public health importance. By handling missing
data, a higher statistical power and accuracy in clinical prediction and biomarker selection
can be retained by FBM given fixed budget and sample size. LDIV effectively increases
genotyping accuracy. CPI simultaneously discovers biological processes that function dif-
ferentially and consensually across studies. It will also assist scientists to explore pathway
findings with reduced redundancy and more statistical backup.
vi
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PREFACE
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of this topic arises from the rapid evolving of high-throughput genomic data generating
technologies, as well as the need of methods to approach the underlying truth behind the
accumulating data. The methods proposed in this thesis include a Bayesian hierarchical
model for multi-omics data with missingness, a genotype inference methods incorporating
both LD and family information, and a pathway integrative analysis framework to capture
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gratitude to Dr. Wei Chen, who has offered his most generous time in training and correcting
me, and preparing me as a bridge between mathematics and clinical research. He is the person
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Lastly, I want to thank my love and my wonderful wife, Xiaoying. You have been a real
blessing to me. We think alike. We read each other’s minds. And I am positive that we
would walk along this path, thinking in the end, how lucky we were keeping each other’s
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1.0 INTRODUCTION
1.1 OVERVIEW OF HIGH-THROUGHPUT OMICS DATA AND
TECHNOLOGIES
Omics refers to the studies of a group of fields ending with -omics in biology, such as
genomics, transcriptomics, epigenomics, proteomics, and etc. PubMed and Google search
entries sees an explosive increase in the use of terms related to omics and omes starting
from mid ’90s (http://bioinfo.mbb.yale.edu/what-is-it/omes/omes.html). Omics data are
essential components to the central dogma in molecular biology (DNA↔ RNA→ Protein)
(Watson, 1965). With the emerging technologies to generate high-throughput omics data
and the methods developed to conduct in-depth analysis on those data, scientists are now
gaining insights into biology processes, and bring to light their associations in pathology.
This section will briefly introduce a few omics data types relevant to this thesis, two major
technologies in omics data generation, and public omics databases.
1.1.1 Genomic data
Genomics data analysis studies information carried by the genomes of organisms. Genomes
are usually consist of DNA (Deoxyribonucleic acid), but are sometimes RNA (Ribonucleic
acid) in RNA viruses. DNA has two strands, stabilizing the storage of genetic material.
Each strand is composed of simpler units named nucleotides of four types, cytosine (C),
guanine (G), adenine (A) or thymine (T). The different combinations of the nucleotide on the
genome translate to the diversity of species and organisms within species. The human genome
contains around 3×109 base pairs nucleotide, distributed among 22 paired chromosomes and
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two sex chromosomes. Only a small fraction of them (approximately 1.5%) (Lesk, 2017) are
protein-coding sequences, meaning they could to be translated and coded into proteins. And
the other parts function as regulatory sequences, associated as non-coding RNA molecules,
and etc.
Although for human beings, the differences among genomes of individuals are only on
the order of 0.1%, this difference explains a great amount of differences in our phenotypes,
or sometimes diseases. Genetic variations are fundamentally brought about by mutations,
which are permanent alterations of nucleotides in genetic materials. Mutations will be carried
through when DNA replicates itself, or be transcribed to RNA, and thus might be expressed
as different protein coding. If the mutation happens in somatic cells and thus only takes effect
for the individual with the mutation but not passed down to offspring, it is called a somatic
mutation, which is usually seen in tumor cells. When mutation happens in reproductive cells
like sperm, it is inheritable, and is called a germ line mutation. Chromosome crossovers and
recombination during meiosis can also bring in genetic variations.
There are various types of genetic variations. Single nucleotide polymorphism (SNP) is
the most common type of genetic variation, it indicates the variation in a single nucleotide. It
has been discovered that over thousands of single nucleotides are potentially associated with
certain phenotypes or diseases through Genome-wide association studies (GWAS) (Hindorff
et al., 2009; McCarthy et al., 2008).
Another type of genetic variation is copy number variation (CNV), a structural variation
with deletion or duplication of a large chromosome region. It has been found that CNV is
associated with disease phenotypes, gene expression regulation, and other genomic processes
(McCarroll and Altshuler, 2007). Other genetic variation includes insertion/deletion (indel)
polymorphism, which represents the addition/missing of a certain nucleotide sequences.
1.1.2 Transcriptomic data
Transcriptomics studies transcriptome, the pool of RNA molecules. RNA is essential in
coding, regulation and expression of genes. Unlike DNA, RNA is single-stranded molecule,
and does not have thymine, but have uracil (G) instead as their bases. There are various types
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of RNA. For a certain gene to be expressed and coded into protein, messenger RNA (mRNA)
is necessary, which is the RNA that conveys information from the genome to ribosome to
instruct the coding of proteins. This step is called transcription. In this step, mRNAs from
the same gene can have various combinations of exons of this gene, and thus produce different
protein isoform in later steps; this phenomenon is called alternative splicing. When mRNA
is in ribosome, transfer RNA (tRNA) transfers amino acids to ribosome, and a catalytic
component of ribosomes, the ribosomal RNA (rRNA), links amino acids to synthesize a
specific protein. This step is called translation. MicroRNA (miRNA) is a short RNA found
in eukaryotes that, along with other types of regulatory RNAs, can down-regulate gene
expression by binding with a part of mRNA or DNA to prevent transcription.
Expression quantitative trait loci (eQTLs) are genomic loci that affect mRNA expression
levels. The eQTLs that are mapped approximately to their original gene location is called
local eQTLs, or cic eQTLs; on contrary, if it is mapped far from original gene location, or
even on other chromosomes, it is referred to as distant eQTLs, or trans eQTLs. Lappalainen
et al. (2013) investigated mRNA, miRNA, together with genetic variations of 462 individuals
from the 1000 Genomes projects, and discovered different types of genetic variations affecting
regulation of most gene in both transcript structures and expression level.
1.1.3 Epigenetic data
Epigenetics studies a pool of epigenetic modifications, reversible modifications that would
not alter DNA sequences on organism’s genetic material. DNA methylation and histone
modification are two most commonly studied epigenetic modifications. DNA methylation
happens when a methyl group is added to cytosine in DNA sequences. And it will repress
the gene expression by reducing accessibility of DNA sequence with methylated cytosine
to transcriptional machinery, for example, RNA polymerase. DNA methylation is generally
related to imprinting, x chromosome inactivation and silencing of repetitive DNA (Schu¨beler,
2015), and for vertebrates, heritable methylation only occurs at CpG dinucleotide, and
approximately 60% of CpG sites are methylated to DNA regions with many repetitive CpG
sites, i.e. CpG island (Bird, 2002). Two values are usually used to measure methylation
3
level, β value and m value. β value is continuous between 0 and 1, indicating the percentage
of methylation events among all cells, and is widely accepted for its interpretability. On the
other hand, m value fits better with Gaussian distribution, and is more valid for statistical
modeling and analysis (Du, 2010). Each of the two values can be transformed to the other
with the following function:
M = log2(β/(1− β))
Histone is the most common type of chromatin, the protein-DNA complexes that condenses
DNA sequences into a 3D coiled structure. Histone modification regulates gene expression
by either disrupting contact between nucleosomes, or nucleosome remodeling.
1.1.4 High-throughput technologies in omics research
1.1.4.1 Microarray DNA microarray technology emerged in early 1990s, and marked
the beginning of high-throughput omics data generation and analysis era. The older tech-
nologies that are therefore replaced by microarray, for example, northern blot, are time
consuming, expensive, and limits gene detection to order of tens, while microarray enables
the detection of thousands of genes or even whole genome gene expression profiling in reason-
able time with a feasible budget. Microarray is made up with array of tens of thousands of
transcript-specific probes on microscope glass slide or silicon chips. If RNA rather than DNA
is to be detected, the RNA samples will first need to be reversely transcribed to cDNA. Then
the DNA is fluorophore-, silver-, or chemiluminescence-labeled to be scanned later. Then
they are hybridized to microarray chips and washed away, while the fluorescence will be cap-
tured by machine with a certain intensity, which corresponds to the gene expression level.
Other than gene expression level profiling, there are other types of microarray chips, for
example, SNP array, for SNP genotyping detection, or copy number variation.
However, there are some limitations of microarray technology. Firstly, it measures the
relative abundance instead of direct count as later technologies like RNASeq, and the signal
is linear only over a certain range of concentration. Secondly, designing array that can be
distinguishable for all genes and all alternative splicing of genes is too difficult. Finally,
microarray cannot detect sequences we have no prior knowledge of, i.e., each array can
4
only capture the specific sequence it is designed for. With those limitations and the rapid
development of new sequencing technologies, microarray becomes less popular, yet is still
competitive in terms of its cost.
1.1.4.2 Next generation sequencing The next-generation sequencing (NGS) technol-
ogy emerged with the increasing demand for inexpensive, accurate and fast generation of
high-throughput omics data (Metzker, 2010). The name next-generation sequencing comes
from its predecessor, automated Sangers sequencing. The development of NGS greatly sped
up scientific findings, and urged statisticians to rethink their methods to apply to the ac-
cumulating big data in omics. There are a wide variety of fields NGS has been applied to,
including whole genome sequencing, exome sequencing, RNA transcriptome profiling (RNA-
seq), bisulfite sequencing for DNA methylation, DNA-protein interaction (ChIP-seq), etc.
NGS is also called shotgun sequencing, due to its unique processing steps: first, the whole
sequence (DNA or cDNA) will be broke down to shorter fragments, which are called reads,
then with PCR amplification technique, each read will have thousands of copies to form a
cluster. The machine will then scan the amplified cluster, and sequencing data is generated.
Multiple platforms are available for this technology, for example, Roche, SOLiD, Illumina,
and so on. After reads are sequenced, algorithms are developed to assemble (de-novo assem-
ble) the reads into a whole sequence, or to align (assemble against reference) reads against a
reference genome. The count of reads mapped to a certain gene is called depth, or coverage,
which serves an important indicator for the intensity of the gene expression, or the quality
and confidence of a certain assembly. The count data are less commonly used compared to
continuous data in statistical modeling, so the count of reads could then be transformed to
continuous value such as TPM (Transcripts Per Kilobase Million), RPKM (Reads Per Kilo-
base Million) or FPKM (Fragments Per Kilobase Million). In the chapter 2 of this thesis,
we will be mainly using TPM to quantify RNA-seq gene expression level.
NGS has several advantages compared to microarray. First, it can identify the transcripts
or sequences not designed or known in hybridization-based approaches, thus it enables many
novel discoveries, for instance, detecting de novo mutation. Secondly, NGS has very low back-
ground signal, greatly increasing the accuracy in both high and low intensity end. Moreover,
NGS also detects larger dynamic range for expression level (Wang et al., 2009).
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1.1.5 Public omics data repositories
Massive data of various omes has been accumulated over the past two decades, due to the
breakthrough advances of high-throughput omics data generating technology. The amount
of data generated, stored and analyzed can foreseeably increase even faster with the dropping
in cost of sequencing technology, and the increase of data storage space and computational
power by Moore’s law. Therefore, public omics data repositories play an essential role in
between data-generating labs, scientists, and statisticians. Starting with genomic data, there
are Encyclopedia of DNA Elements (ENCODE, The ENCODE Project Consortium (2012))
and its extension, MODel organism ENCyclopedia Of DNA Elements (modENCODE, Ger-
stein et al. (2010)) project serving to identify and annotate functional elements of human
genome. The 1000 Genome Project (IGSR, The 1000 Genomes Project Consortium (2015))
aims to find most relatively common genetic variants with minor allele frequency greater
than 1%. One popular kind of studies to find the association between phenotype and hu-
man genome is the genome-wide association studies (GWAS). Hundreds of GWAS (GWAS
Catalog, www.ebi.ac.uk/gwas) are conducted in the past decades, and stored in Genotypes
and Phenotypes databases (dbGaP). For transcriptomic data, there are Gene Expression
Omnibus (GEO, Edgar et al. (2002)), Sequence Read Archive (SRA, Leinonen et al. (2011)),
and Array Express (www.ebi.ac.uk/arrayexpress). There are also worldwide or nationwide
consortium focusing on collecting omics data within a certain domain, one of the largest
is The Cancer Genome Atlas (TCGA, Weinstein et al. (2013)) initiated by National Caner
Institute. TCGA has a wide collection of a total of 33 cancer types with DNA mutation,
CNV, RNA gene expression, miRNA expression, protein expression, DNA methylation, etc.
The numerous types of omics data publicly available provided both opportunities and
challenges in a statistical domain named vertical omics data integration. This concept will
be introduced in next subsection.
6
1.2 VERTICAL OMICS DATA INTEGRATION
With the accumulation of high throughput multiple omics data from numerous labs, a do-
main named omics data integrative analysis arose. There are two types of omics data inte-
gration, the horizontal integration, and the vertical integration. The former one combines
studies/cohorts with the same omics data types, e.g., transcriptomic studies, and aims on the
gain of statistical power and reproducibility by integrating them. The latter one is relative
to Chapter 2; it combines multi-omics data from the same cohort of individuals, investi-
gates the inner regulatory mechanisms in between omics data (e.g. gene expression, eQTL,
and DNA methylation), and seeks to gain deeper insight into the corresponding biological
processes. A few successful examples in vertical meta-analysis are ovarian cancer (Can-
cer Genome Atlas Research Network, 2011), breast cancer (Cancer Genome Atlas Network,
2012), and stomach cancer (Cancer Genome Atlas Research Network, 2014) from TCGA.
There are also vertical integration methods developed for different purposes. For example,
for the purpose of prediction on a clinical outcome yet being able to uncover the regulatory
mechanism between omics data types, Wang et al. (2012) proposed integrative Bayesian
analysis of genomics data (iBAG). And for the purpose of clustering, a few examples are:
Bayesian consensus clustering (BCC) fitting a finite Dirichlet mixture model, allowing for
both common and omic-specific clustering patterns (Lock and Dunson, 2013); iCluster used
matrix decomposition and regularization in latent variables to help clustering (Shen et al.,
2009a), sparse k-means clustering allows clustering with overlapping feature groups (Huo
and Tseng, 2017a).
In Chapter 2, we focus on iBAG model for vertical omics integration, with the aim
of prediction and feature selection. Our model is able to discover inner regulatory mech-
anisms between different omics data types (in our example, RNAseq gene expression and
DNA methylation), and our model also incorporate missing value handling, which will be
introduced in the next subsection.
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1.3 MISSING DATA IMPUTATION IN OMICS STUDIES
Missing data can exist in almost all types of statistical analyses. One way to categorize
missing data is by a typology by Rubin (1976), or the three missing assumptions. First
one is missing complete at random (MAR). Assuming a generic notation, where R are the
probabilities of missingness, and data Y are partitioned to two part, Ycom = (Yobs, Ymis), and
that:
P (R|Ycom) = P (R|Yobs)
This means the distibution of missingness does not depend on missing data Ymis. A spe-
cial case of MAR is missing complete at random (MCAR), which further assume missing
probability does not depend on Yobs, i.e.
P (R|Ycom) = P (R)
MAR and MCAR together are called ignorable missingness, as in these cases one can ignore
the model of missingness, i.e. no need to model R. Yet the missing data itself is still essential
and usually need to be modeled.
A third missing assumption is called missing not at random (MNAR), which happens
when MAR assumption is violated. MNAR is also called non-ignorable missingness, and is
substantially harder to deal with when modeling (Schafer and Graham, 2002). Unfortunately,
in real data, there is no way to examine those assumptions, because those missing data per
se could not be observed.
Another way to categorize missing data is by exchangeability, where exchangeable means
the distribution of missing data (not R, the missingness) does not depend on other observed
data, and that nonexchangeable means that the distribution of missing data depend on other
observed data.
Same as other statistical problem, missing data is inevitable in omics data analysis. This
can be due to various technical limitations (Aittokallio, 2010; Albrecht et al., 2010). Those
types of missing usually come with smaller percentage (e.g. less than 10%), and numerous
methods have been developed to address it. However, in vertical integrative analysis of omics
data, another type of missing will occur by the mismatch of data types of samples. Since in
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integration, it is likely that not all samples are measured with all omics data, the sample size
will be drastically reduced when taking intersection across all omics data (Lin et al., 2016).
And the missing proportion for this missing type could usually be more than 30%, and will
be a more severe hindrance to the integration than the previous type. Therefore, chapter 2
will mainly deal with this type of missing.
Numerous methods have been developed to deal with missing data in general as well as
domain-specific. Without imputation, complete case (CC) analysis is an unbiased method
under MAR assumption, which is the approach by simply taking the cases with complete
data for further analysis. Yet the power decrease is worth noting especially when missing
proportion is large. Among imputation methods, a few of the most generic ones are: mean
substitution, hot deck, conditional mean, and predictive distributions (Schafer and Graham,
2002). Multiple imputations (MI), impute by generating K > 1 imputed values for missing
observations from appropriate probability distribution, are proven to be a robust substitution
for aforementioned imputation methods (Rubin, 1987), and is gaining its popularity with the
development of MCMC approaches. Lastly, in full Bayesian model, missing data are treated
the same as parameters, and therefore need to be modeled, and then estimated or sampled,
in a similar fashion. There are also imputation methods specifically developed for missing
problem in omics data. For example, Voillet et al. (2016) applied multiple imputations to
multiple factor analysis; Lin et al. (2016) imputes missing data by taking into account the
correlation across different omics data in vertical integration.
In Chapter 2, we will propose our full Bayesian framework with missing data imputation
modeled together with parameter estimation and feature selection.
1.4 BAYESIAN MODELING FOR PREDICTION AND FEATURE
SELECTION
Bayesian inference solves statistical problems by building probability model to data, using
parameters of the model to generate probability distributions, and hence summarizing the
results (Gelman et al., 2014). Different from frequentist inference, Bayesian inference assumes
true parameters are from certain distributions with variance, instead of fixed. A standard
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Bayesian process could be summarized as three steps:
• Setting up full probability model, which is a joint probability distribution of all observed
and missing data.
• Calculate the appropriate posterior distribution conditioning on observed data. This
step follows the Bayesian rule that P (M |D) ∝ P (M) × P (D|M), where D means the
fully observed data, M means the full parameter set, and thus P (M |D) is the posterior
distribution, P (M) is the prior distribution, and P (D|M) is the likelihood.
• Evaluate the model by checking model fitting, if conclusions are reasonable, and con-
ducting sensitivity analysis.
Since mathematically, step 2 requires taking expectation of integrals to derive the posterior
distribution, it is usually hard or even impossible to find analytical solution to this problem.
Therefore, although Bayesian inference emerged over two hundred years ago, it is not popular
until the development of Monte Carlo Markov chain (MCMC) algorithms and the booming of
modern computation technologies. MCMC is by nature a random walk algorithm, with idea
of stochastically sampling parameter in its parameter space, while keeping Markov property,
i.e. the status in current iteration, conditional on one previous iteration, is independent on
all earlier iterations (Gelman et al., 2014). Metropolis-Hastings (MH) is one of the most
famous and conventional methods for MCMC. It first generates proposal distribution, then
by accept-reject criteria to decide the distribution to sample from in the next iteration
(Metropolis et al., 1953; Hastings, 1970). One typically applied special case of MH is Gibbs
sampling (Geman and Geman, 1984), where the conditional distribution is used as sampling
distribution.
Bayesian approaches are gaining increasing popularity in many statistical domain, in-
cluding omics data analysis. This is due to several advantages of it compared to frequentist
inference. First, Bayesian inference allows taking prior distribution of parameter into the
model, thus is suitable for omics data analysis where some prior knowledge are obtained
from scientific experiments. Secondly, Bayesian inference allows establishing of relatively
complex models in multiple layers, called Bayesian hierarchical model, with no substantial
modeling difficulty added. The model flexibility makes it suitable for addressing correlation
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relationship between multiple omics data types and outcomes. Another merit of Bayesian
inference is its ease of interpretation for results, i.e. usually probability is given instead of
p-value in frequentist analysis.
An increasing amount of Bayesian methods have been developed for omics studies. Many
of them aim at prediction and feature selections, for example, iBAG (Wang et al., 2012) use
Laplacian priors (Park and Casella, 2008) to put shrinkage on parameters for feature selec-
tion, and therefore detect important genes or biomarkers associated with clinical outcome;
Ishwaran and Rao (2005) use spike-and-slab prior (George and McCulloch, 1993) to identify
biologically important signals while minimizing false discoveries in multi-group microarray
data.
In Chapter 2, we will discuss in detail a full Bayesian model to integrate multiple omics
data types for clinical outcome prediction, feature selections, and full Bayesian missing data
imputation.
1.5 STATISTICAL INFERENCES IN GENOTYPE CALLING
The magnitude of genetic variants confidently discovered by next generation sequencing
(NGS) technologies has empowered a variety of biologically meaningful downstream analysis.
For instance, genome-wide association studies (GWAS) (Genomes Project Consortium et al.,
2012) have revealed significant association between thousands of genetic variants with traits
or diseases. The majority of those variants are single nucleotide polymorphisms (SNPs). A
first and fundamental step of the NGS downstream analysis is called genotype calling, which
is the step for inference of the genotypes of those SNPs based on raw sequencing reads. An
accurate genotype calling is crucial and the prerequisite for any further downstream analysis
based on SNPs detected. It has been shown that low-depth sequencing, which means the
average sequencing read depth on each sites is relatively low (<5X) or moderate (<10X),
could be more powerful and cost-efficient, when an appropriately larger sample size is used
(Li et al., 2011). Large sequencing projects like 1000 Genome Project, UK10K project and
the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Project
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has been taking this low-depth large-cohort strategy, for example, 1000 Genome Project
sequenced 2535 subjects at the depth of 4-6X. Yet due to a non-ignorable per-base error
during the sequencing, uncertainty of low-depth genotype calling could be high, therefore
sophisticated likelihood-based methods are almost always required for an accurate call.
Existing accurate genotype calling methods developed for low-coverage sequencing sce-
narios could be divided into two categories, based on the extra constraints and information
they consider apart from raw sequencing reads. One category of methods improve geno-
type calling accuracy by considering the linkage disequilibrium (LD) between SNPs. Hidden
Markov models (HMM) are often required in inferring the LD patterns, a few examples are
Thunder, MaCH, and Beagle4. There are also methods doing inference using EM algorithm
for the same purpose, for example, PedHapGC (Zhou and Whittemore, 2012). The sec-
ond category of methods are developed as family-based sequencing projects emerged and
showed its strengths in detecting rare SNPs, studying parent-offspring origins, etc. These
methods take pedigree structures, presented in identity-by-descent (IBD) information, into
consideration. In this category, PedHapGC uses EM-algorithm-based approach to account
for pedigree constraints; more other methods are based on HMM. For example, TrioCaller
(Chen et al., 2013) is developed to address parents-offspring trio family structure; FamLD-
Caller (Chang et al., 2016) further considered general family structure by looping through
each parent-offspring trio within a family; Polymutt2 (Li et al., 2015) uses inheritance vec-
tor to represent IBD pattern, which considered not only the parent-offspring Mendelian
constraints, but also the information shared between siblings; and lastly, the methods we
propose in chapter 3 of this thesis, namely LDIV, leverages both LD and pedigree infor-
mation for jointly inference of the genotypes. Other than these two main categories, some
other popular methods are GATK (McKenna et al., 2010) and SamTools (Li et al., 2009),
which takes neither of the aforementioned information. Though being useful for preliminary
calls, simulation and real data analysis shows that these methods are less powerful in the
preferable low-coverage large-cohort sequencing scenarios.
In Chapter 3, we propose our statistical methods named LDIV to address the above
issue. And we benchmark the performance of each method in different sequencing scenarios,
with varying sequencing depths, per-base error rate, and family structure.
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1.6 PATHWAY ENRICHMENT ANALYSIS
In a typical transcriptomic study, a set of candidate genes associated with diseases or other
outcomes are first identified through differential expression analysis. Then, to gain more in-
sight into the underlying biological mechanism, pathway analysis (a.k.a. gene set analysis) is
usually applied to pursue the functional annotation of the candidate biomarker list. The ra-
tionale behind pathway analysis is to determine whether the detected biomarkers are enriched
in pre-defined biological functional domains. These functional domains might come from one
of the publicly available databases such as Gene Ontology (GO) and the Kyoto Encyclopedia
of Genes and Genomes (KEGG). Three main categories of pathway analysis methods have
been developed in the past decade. The first method called ”over-representation analysis”
considers biomarkers at a certain DE evidence cutoff and statistically evaluate the fraction
of DE genes in a particular pathway found among the background genes. Without a hard
threshold, the second category ”functional class scoring” takes the DE evidence scores of all
genes in a pathway into account and aggregates them into a single pathway-specific statistics.
The third category ”pathway topology” further incorporates the information of inter-gene in-
teraction and their cellular location in addition to the pathway database (Khatri and Butte,
2012).
Pathway analysis methodology for single study is a relatively mature field (Huang et al.,
2009), yet methods for pathway analysis in integrative studies is lacking (Shen and Tseng,
2010). A meta-analytic pathway analysis approach that allows the discovery of both con-
sensual and differential pathway enrichment patterns will be introduced in chapter 5.
1.7 OVERVIEW OF THE DISSERTATION
My disseration contains five chapters. Chapter 1 contains introduction of high-throughput
omics data and technologies, statistical methods motivated by the integration and missing
data in multiple omics data analysis, basic knowledge in Bayeisan data analysis, genotype
calling methods, and pathway enrichment analysis methods. This chapter serves as the back-
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ground knowledge and motivation for methodology development and application in Chapter
2, 3 and 4.
Chapter 2 introduced a full Bayesian hierarchical model for vertical multi-omics data
integration, with missing data handling. Inspired by iBAG model, our model has non-linear
feature selection empowered by spike-and-slab prior, and use three layers of Bayesian model
to incorporate data integration and imputation simultaneously. In addition, we developed a
cross-validation-based approach to facilitate user choosing best strategy when facing missing
data in vertical integration. The content in this Chapter is under review at Bioinformatics.
Chapter 3 introduced a HMM-based model, namely, LDIV (linkage disequilibrium and
inheritance vector), to improve genotype calling in family-based sequencing data. In this
model, both linkage disequilibrium (LD) patterns and inheritance by descent (IBD) pedi-
gree constraints are comprehensively incorporated, and the genotype likelihoods are jointly
inferred in a family. This method is both accurate and computationally feasible.
Chapter 4 introduced a framework of meta-analytical integration of multiple transcrip-
tomic studies for consensual and differential pathway analysis, wrapped in a tool named
Comparative Pathway Integrator (CPI). Our tool incorporates 24 pathway databases, and
is able to identify both commonly and study-specifically enriched pathways, empowered by
adaptively weighted Fisher’s method. This tool also reduces pathway redundancy analysis
by clustering analysis based on the overlapping genes among enriched pathways, and auto-
mates the annotation of pathway clusters by text mining, offering more statistically valid
summarization. CPI also provides users both text and graphical outputs for intuitive while
statistical solid presentation and easy interpretation. The content in this chapter is under
preparation.
Chapter 5 is the discussions and future works. We will apply our LDIV methods to
real studies. We also propose to do a comprehensive comparison and review of all current
genotype calling methods to give the scientific community an informative guideline.
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2.0 A BAYESIAN MODEL FOR INTEGRATING HIGH-THROUGHPUT
MULTI-OMICS DATA WITH MISSINGNESS HANDLING
2.1 INTRODUCTION
Multi-level omics data refer to the combined molecular data in various types, for example
genome, transcriptome, methylome and proteome data, measured on a common cohort of
patients. The availability of multi-level omics data in both magnitude and varieties poses
challenges as well as opportunities to understand fundamental mechanisms of diseases and
pathologies. Compared to separately discovering the association patterns between each omics
data and phenotypes, an integrative framework that simultaneously integrates multiple omics
data types will uncover more insightful regulatory machineries between different omics data,
and will hence deepen our understanding to hereditary and environmental causes in pathol-
ogy (Richardson et al., 2016; Tseng et al., 2012, 2015).
In the literature, many strategies have emerged for integration of multi-omics data. To
cluster samples for identifying unknown disease subtypes, integrative clustering (iCluster;
Shen et al., 2009b), Bayesian consensus clustering (BCC; Lock and Dunson, 2013), group
structured integrative clustering (GS-iCluster; Kim et al., 2017) and integrative sparse K-
means (IS-Kmeans; Huo and Tseng, 2017b) have been developed for integrative clustering
of multi-omics data. For association and prediction modeling, iBAG (Wang et al., 2012) in-
vestigates association patterns of mRNA expressions and methylation with clinical outcome
via a mechanistic model for associating methylation with gene expression and then a clinical
model for direct association between expression and clinical outcome or via methylation. A
Bayesian hierarchical model is then established for the inference. Such Bayesian hierarchical
modeling has gained popularity in multi-omics integrative analysis due to its flexibility in
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model construction for complex regulatory structure, convenience to incorporate prior bi-
ological knowledge and advances in modern computing. In the association and prediction
modeling, we usually focus on two key goals in the inference: firstly, to select predictive
biomarkers for the phenotype and secondly, to predict clinical outcome from the selected
biomarkers. As tens of thousands of features are available in omics data, the first goal of
feature selection is essential in interrogating the biological and pathological mechanism of a
targeted disease. The second goal could be of immediate clinical use, for example, assisting
diagnosis of a disease, directing the best treatment decision and predicting drug response.
One obstacle for applying multi-omics integrative methods in real applications is missing
data. Due to various reasons(e.g. limited budget, bad tissue quality or insufficient tissue
amount), it is common that only partial samples have all omics data types (Voillet et al.,
2016). For example, TCGA breast cancer study had 922 samples measured in methylation
array, yet only 781 were measured in miRNA expression and 587 were measured for gene
expression. Almost 40% of the samples are missing at least one type of omics data. To
circumvent this pitfall, a na¨ıve and convenient solution is by complete-case (CC) analysis,
where samples with any missing measurement are ignored. This approach results in dra-
matic decrease of sample size and thus decreases of statistical power, especially when more
omics data types are combined. The shortcoming of CC in omics studies is recently no-
ticed by statisticians, for example, Voillet et al. (2016) who developed a multiple imputation
approach focusing on multiple factor analysis for multiple omics data. However, a unified
framework serving the aforementioned purpose of feature selection, prediction, as well as
missingness handling is still lacking. In this paper, we are motivated by the iBAG model
combining mRNA expression methylation, clinical variables to predict a targeted continuous
outcome. We propose a full Bayesian model with missingness (FBM) that allows iBAG to
handle situations when partial samples are missing with mRNA expression or methylation.
Extensive simulations and real applications demonstrated superior performance in feature
selection and prediction accuracy of the new approach compared to na¨ıve complete-case ap-
proach. The model can be extended to other omics data types or other targeted outcomes
(e.g. binary or survival).
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     The paper is structured as the following. In Chapter 2.1, we introduce the motivation, the
original iBAG model and the proposed FBM. Chapter 2.2 discusses the inference of pre-
diction and feature selection of FBM (Chapter 2.2.1) and evaluation benchmarks (Chapter 
2.2.2). Chapter 3 contains extensive simulations to evaluate performance of FBM and Chap-
ter 4 proposes a cross-validation (CV) decision scheme to determine whether and how to 
incorporate samples with missingness in FBM. Chapter 5 includes an application to a child-
hood asthma dataset with 460 individuals. Final conclusion and discussion are presented in 
Chapter 6.
2.2 METHODS
2.2.1 Motivation and the full Bayesian model with missingness
2.2.1.1 Motivation IBAG is a two-layer Bayesian hierarchical model for vertical inte-
grative analysis of multi-level omics data, assuming data are complete. However, in reality, 
a large proportion of missing data is commonly seen due to budget or limitation in tissue 
collection. Figure 1a gives an example of data structure with missingness. Suppose there are 
a total of N samples, Y indicates the clinical outcome of interest; C indicates clinical factors;
GN×K = (G′obs,NGobs×K
,G′
mis,NGmis×K
)′ indicates the gene expression with missingness, where
UG = (UG1 , ...U
G
N ) is the missing indicator; likewise, MN×J = (M
′
obs,NMobs×J
,M′
mis,NMmis×J
)′
indicates methylation data with missingness, where UM = (UM1 , ...U
M
N ) is the missing in-
dicator. U = 1 indicates missing and U = 0 indicates observed. For example, number of
samples with methylation level missing is NGobs = N −
∑K
k=1 U
G
k . We assume U
M
i × UGi 6= 1
for ∀ 1 ≤ i ≤ N . The original iBag model takes only the complete data and is subject to
loss of statistical power. To handle missingness, we propose a full Bayesian model with miss-
ingness inspired by iBAG model, to achieve three goals simultaneously: feature selection,
prediction, and missing data imputation. In Chapter 2.1.2, we briefly introduce the iBAG
model. In Chapter 2.1.3, we propose our full Bayesian model for multi-omics integration
with missingness imputation.
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Figure 1: Illustration of missing pattern and model parameters.
a) Illustration of missing pattern adopted in this paper. Slash-shaded area represents missing
data, cross-shaded area represents value 1 for missing indicator vectors UG and UM . b) DAG
of the model and parameters. The square in the DAG denotes observed data, solid circle
denotes variable to be updated, circle in grey color is the variable of interests, dashed circle
denotes prior. Solid arrows indicate stochastic dependencies, and dashed arrows indicate
deterministic dependencies.
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2.2.1.2 iBAG In iBAG, the mechanistic models in the first layer assess gene-methylation
effect and divides gene expressions into two parts, the part regulated by methylation (GM)
and the part regulated by other mechanisms (GM).
G = GM + GM ,GM = MΩ,
where GM = (gMnk)N×K = (g
M
1 , ...,g
M
K ), G
M = (gMnk)N×K = (g
M
1 , ...,g
M
K ), Ω = (ωjk)J×K : ωjk
denotes the ”gene-methylation” effect that estimates the (conditional) effect of jth methy-
lation feature on the kth gene.
The second layer called clinical model assesses the association between gene expression
(GM and GM) and the phenotype:
Y = CγC + GMγM + GMγM + ,
where γC = (γC1 , ...γ
C
L ) : γ
C
l denotes the effect of the lth clinical factor on the clinical outcome
Y. γM = (γM1 , ...γ
M
K ) : γ
M
k denotes the gene expression effect of g
M
k on clinical outcome Y,
called a type M effect. γM = (γM1 , ...γ
M
K ) : γ
M
k denotes the gene expression effect of g
M
k on
clinical outcome Y, called a type M effect.
2.2.1.3 Full Bayesian model with missingness Figure 1b gives a full representation
of our model. Our model contains three parts: mechanistic model, clinical model, and an
imputation model derived from the previous two models. The mechanistic model and clinical
model stem from the iBAG model introduced in Chapter 2.1.2. Here, we will focus on two
novel parts added to the original iBAG model: the sparsity-induced spike-and-slab priors
(Ishwaran and Rao, 2005) for feature selection in both mechanistic and clinical models, and
an imputation model to deal with missing omics data.
There are a total of 8 groups of parameters that need to be estimated: γM , γM , γC , Ω,
σ2k’s, G
mis, Mmis, σ2. γM and γM are our parameters of interests. Investigators may also find
Ωs important if they are interested in further inference on methylation-gene regulation. The
corresponding Monte Carlo Markov Chain (MCMC) Gibbs sampler will be further discussed
in Appendix.
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The original iBAG model placed a Laplace prior on γM and γM for shrinkage purpose,
however, it does not set the effects to exact zeros. To conduct natural variable selection, we
instead use a spike-and-slab prior to induce sparsity. In addition, we also perform feature
selection in ω using the same spike-and-slab prior, considering that not all the methylation
sites are regulating the gene expression. So we will have:
[
γMk |IMk , (τM)2
] ∼ (1− IMk )δ0(·) + IMk N(0, (τM)2);
[
IMk |piM
] ∼ Bern(piM), [piM] ∼ Unif(0, 1);[
γMk |IMk , (τM)2
]
∼ (1− IMk )δ0(·) + IMk N(0, (τM)2);[
IMk |piM
]
∼ Bern(piM),
[
piM
]
∼ Unif(0, 1);[
ωj|Iωj , (τω)2
] ∼ (1− Iωj )δ0(·) + Iωj N(0, (τω)2);[
Iωj |piω
] ∼ Bern(piω), [piω] ∼ Unif(0, 1);
where IMk , I
M
k and I
ω
j are binary indicators and δ0(·) = N(0, 10−6) represents a narrow
spike and τ 2 represent the wide slab. A Jeffery’s prior is put on (τM)2, (τM)2, (τω)2, i.e.:
[
(τM)2
] ∝ (τM)−2, [(τM)2] ∝ (τM)−2, [(τω)2] ∝ (τω)−2.
For Gmis and Mmis (Figure 1b), we impose the following imputation model:
gmis,k ∼MVNNGmis×NGmis(MJkωk, σ2kINGmis×NGmis);
mmis,j ∼MVNNMmis×NMmis(0, (σm)2INMmis×NMmis),
where MVN denotes the multivariate normal distribution and (σm)2 = 1 if the methylation
value is already standardized with mean 0 and standard deviation 1. Note that here we
assume the methylation data are in M value according to Pan et al., 2010. If β value is
to be used, we may need to replace the above prior with a truncated normal distribution
bounded between 0 and 1. All other variables are given non-informative priors. Details can
be found in the Appendix.
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• In our model, we assume that the methylations are many-to-one mapped to genes, i.e.,
only the methylation within the promoter region of the gene is mapped to the gene, and
each methylation will only be mapped to one gene. The mapping is also assumed to
be known from biology background knowledge in our model. The methylation level is
centered around 0 if we are using m-value.
• It is reasonable and necessary to assume that if for all the ωj where j are within the
promoter region of gene k, we let Iωj = 0, then we automatically have I
M
k = 0. I.e.,
IMk 6= 0 only when at least one methylation is selected.
• In cases where there are more than a few methylation sites mapped to each gene, prin-
cipal component analysis (PCA) is recommended on methylation sites per gene, and the
first few PCs explaining large proportion of variation can be used in place of original
methylation level. This takes advantage of the high correlation between methylation
sites.
2.2.2 Inference and evaluation
The full Bayesian hierarchical model in the last section allows fast Gibbs sampler. Full
conditional formula for iterative sampling are shown in Appendix. The final parameter
estimates are calculated by averaging stabilized MCMC iterations (i.e., removing the first
Br burn-in period in MCMC iterations). The burn-in period Br is determined using Geweke’s
convergence diagnostics (Geweke et al., 1992). Geweke diagnostics aims to test whether the
first a% and last b% of the MCMC iterations have equal mean, and thus decide whether the
samples are drawn from a stationary distribution. As suggested by Geweke, the first 10% of
MCMC total iterations are taken as burn-ins once the MCMC chain pass the diagnosis.
2.2.2.1 Prediction and feature selection The Bayesian integrative model generates
two major inference outcomes: prediction and feature selection. For prediction, denote γˆC(b),
γˆM(b), γˆ
M
(b), and Ωˆ(b) as the simulated parameter estimates from the b-th iteration. For a new
sample with omics data (Cnew, Gnew, Mnew), we average prediction of y from the (B −Br)
stable MCMCs by yˆnew = (
∑B
b=Br+1
yˆ
(b)
new)/(B −Br), where yˆ(b)new = Cnew · γˆC(b) + Mnew · Ωˆ(b) ·
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Remarks:
γˆM(b) + (Gnew −Mnew · Ωˆ(b)) · γˆM(b).
Next, we summarize feature selection indicators IMk,(b) and I
M
k,(b) for gene k and the b-th
MCMC to determine the set of genes predictive to outcome y. Given the b-th iteration,
we define the selection indicator for gene k as Ik,(b) so that gene k is selected if either the
impact on outcome is through methylation (IMk,(b)) or not (I
M
k,(b)). In other words, Ik,(b) =
(IMk,(b)) OR (I
M
k,(b) = 1− (1− IMk,(b))(1− IMk,(b)) for Br + 1 ≤ b ≤ B and 1 ≤ k ≤ K. To control
FDR at gene level, we apply Bayesian FDR (BFDR) proposed by Newton et al., 2004:
BFDR(t) =
∑K
k=1 Pˆk(H0|D)dk(t)∑K
k=1 dk(t)
where Pˆk(H0|D) = 1 − (
∑B
b=Br+1
Ik,(b))/(B − Br) is the posterior probability of gene k
belonging to null hypothesis H0 (i.e. gene k is not selected given observed data D), dk(t) =
I(Pˆk(H0|D) < t), and t is a tuning threshold. Given the definition of BFDR, the q-value of
gene k can be defined as qk = mint≥Pˆk(H0|D)BFDR(t). This q-value will later be used for
feature selection decision, which is comparable to frequentist approaches. Among selected
genes, one may perform post hoc analysis to further investigate cMk = (
∑B
b=Br+1
IMk,(b))/(B −
Br) and c
M
k = (
∑B
b=Br+1
IMk,(b))/(B − Br) and determine whether the impact of gene k to
outcome is through methylation, non-methylation or both.
2.2.2.2 Benchmarks for evaluation To evaluate the performance, the basic approach
we compare to is the complete case (CC) analysis. For full Bayesian model with missingness,
we will also choose to impute gene expression only (FBMG), methylation only (FBMM) or
both (FBMGM) when applicable. In simulation studies, we also perform analysis of the
complete data (full) to examine the reduction of accuracy caused by missingness.
To benchmark performance of outcome prediction, we consider RMSE:
RMSE =
√√√√ N∑
i=1
(yi − yˆi)2/N
In simulation studies, after parameter estimates are obtained we generate a new testing
dataset with large sample size (N = 2000) and compute RMSE. In real data analysis, we
perform 50-fold cross-validation on complete cases for RMSE evaluation. In each iteration,
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2% of complete-case samples are set aside as test dataset, all remaining data are used to
perform CC and FBMs analyses. The parameter estimates are then applied to the test data
for outcome prediction. After ten iterations, cross-validated RMSE can be evaluated on all
complete-case samples.
To evaluate feature selection performance, we order genes by q-value, plot receiver oper-
ating characteristic (ROC) curves and calculate area under curve (AUC) in simulations since
the underlying true predictive genes are known. For real data, since we do not know the
true features, we treat the gene selection result from full data analysis (full) as a surrogate
of gold standard and compare gene selection from CC (or FBMs) to the full data analysis by
tracing the top number of selected genes on the x-axis (e.g x=100 top selected genes by CC
and full) and the overlapped number from CC and full on the y-axis (Figure 4b). Comparing
the curves of CC and FBMs, a higher curve closer to the diagonal line shows more similar
gene selection to ”full” and thus an indication of better performance.
2.3 SIMULATION STUDIES
2.3.1 Simulation schemes
To evaluate performance of our full Bayesian model with missingness, we perform simulation
based on data structure described in Chapter 2. Specifically, the clinical and methylation
data matrices are simulated from N(0, 10) and N(0, 1) with N = (50, 100, 200, 500), L = 2
and J = 2, 000. Each methylation site is randomly assigned to a gene, with the constraint
that each gene contains at least one methylation site. In the mechanistic model, Iωj = 1,
ωjk = 5 and σ
2
k = 4 for 1 ≤ j ≤ J and 1 ≤ k ≤ K, where the total number of genes K = 1000.
We then simulate gene expression matrices from N(MΩ, diag(σ21, ...σ
2
K)). In the clinical
model, 10 genes are randomly selected to impact clinical outcome through methylation and
10 randomly impact not through methylation (i.e. The IM vector has 10 out of K genes
equal one and the remaining are zero, and similarly for IM¯ . The selected genes in IM and
IM can possibly overlap). For selected genes in IM and IM , the corresponding γMk and γ
M
k
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are set to 10. The coefficients for clinical data γCl (1 ≤ l ≤ L) are also set at 10 and σ2 = 9
to simulate clinical outcome Y .
After full multi-omics datasets are simulated, data with missingness are generated with
α% of samples with missing gene expression data and another non-overlapping β% of samples
with missing methylation data. We simulate three scenarios of missingness: (I) Missing only
gene expression data with (α, β)=(0.1,0), (0.2,0) and (0.5,0); (II) Missing only methylation
data with (α, β)=(0,0.1), (0,0.2), (0,0.5); (III) Non-overlapping samples missing either gene
expression or methylation data with (α, β)=(0.1,0.1), (0.2,0.2), (0.3,0.3). For Scenario I,
we evaluate CC and FBMG approaches and compare with full. Similarly for Scenario II,
we compare CC, FBMM and full. Finally for Scenario III, we compare CC, FBMG, FBMM ,
FBMGM and full. In this case, FBMG imputes gene expression but ignores samples with
missing methylation and similarly, FBMM imputes methylation but ignores samples with
missing gene expression. FBMGM utilizes all samples and imputes both gene expression and
methylation.
2.3.2 Results
Figure 2 shows the outcome prediction performance by RMSE for all three scenarios. We
first focus on small sample size situations N = 50− 200. In Scenario I, CC, FBMG and full
have similar performance when α = 10% missing but FBMG clearly outperforms CC when
missingness increases to 20% and 50%, showing the benefit of imputation as expected. In
contrast, FBMM performs much worse than CC in Scenario II with β = 10% methylation
missingness and FBMM only slightly outperform CC when missingness increases to 50%.
Results of Scenario III are consistent with results of Scenarios I and II. FBMM and FBMGM
performs worse than CC at α = β = 10%. FBMM , FBMG and FBMGM outperforms CC
at α = β = 50%. It is worth noting that when sample size increases to N = 500, the
data information is strong enough such that CC has performance similar to full. Imputation
almost always create more data uncertainty and have worse performance than CC, especially
since the majority of the imputed data are irrelevant to the clinical outcome.
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Figure 2: Model prediction by RMSE(yˆ) comparing different methods and full data.
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Figure 3: The ROC curves for feature selection comparison on Scenario I.
α 6= 0, β = 0. Star on each ROC curve is the point with maximum Youden index.
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We next examine feature selection performance by AUC values in Table 1 (ROC curves
shown in Supplement Figure 20a-c). In Scenario I, FBMG always has higher AUC values
than CC especially when missingness α increases to 25% or 30%. On the contrary, FBMM
has lower AUC than CC except for N = 50, 100 in β = 50%. The message becomes mixed
in Scenario III as expected.
In summary, since methylation is the up-regulator of gene expression and indirectly
impact the clinical outcome, imputing methylation is generally less effective than imputing
gene expression. With increasing missing proportion, the benefit of imputation escalates.
But when the missing proportion is small or sample size large, imputation may only introduce
data uncertainty and the performance becomes worse than complete case.
2.4 IMPUTE OR NOT: A DECISION SCHEME BY CROSS-VALIDATION
From the mechanistic model in Figure 1b, gene expression and methylation data are not
symmetric. Methylation data can be predictive to gene expression data and further predictive
to outcomes. On the other hand, gene expression data are less predictive to methylation
to help outcome prediction. As we have shown in simulations, imputations do not always
improve prediction performance compared to complete case analysis. Whether imputation
would improve outcome prediction depends on the types of missingness (missing the upstream
methylation data or missing the downstream gene expression data or both), the proportion
of missingness and sample size. To guide the decision, we propose a self-learning cross-
validation (CV) scheme. Specifically, we apply 10-fold cross-validation by leaving 10% of
complete-case samples as the test set (for Scenario III N=500, we apply 50-fold CV). We
apply CC, FBMG, FBMM and FBMGM to the remaining training data, calculate parameter
estimates and apply to test set. The procedure is repeated across all 10 folds and RMSE can
be calculated on all test sets. The method with the smallest RMSE is selected to determine
whether and how to impute. We note that to evaluate performance of CV scheme in RMSE
evaluation of outcome prediction in the Chapter 5, nested cross-validation will be used (i.e.
An outer loop of cross-validation is used to evaluate RMSE and an inner loop of CV scheme
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Table 1: AUC of different methods in simulation studies
Scenario I Scenario II Scenario III
Missing N Full CC FBMG CC FBMM CC FBMG FBMGM FBMM
L
ow
*
50 0.676 0.649 0.672 0.631 0.613 0.616 0.628 0.652 0.583
100 0.899 0.867 0.878 0.883 0.777 0.826 0.753 0.826 0.703
200 0.967 0.976 0.983 0.961 0.863 0.946 0.859 0.913 0.789
M
ed
*
50 0.676 0.619 0.665 0.626 0.597 0.574 0.61 0.646 0.528
100 0.899 0.813 0.862 0.807 0.774 0.762 0.745 0.826 0.699
200 0.967 0.941 0.961 0.939 0.861 0.903 0.858 0.917 0.795
H
ig
h
*
50 0.676 0.53 0.637 0.557 0.588 0.534 0.583 0.636 0.512
100 0.899 0.699 0.835 0.681 0.742 0.638 0.75 0.833 0.7
200 0.967 0.892 0.964 0.88 0.814 0.828 0.782 0.883 0.765
*Low, medium, and high missing proportion for Scenario I and II are 10%, 25% and 50%
for either α or β, respectively; and for Scenario III is 10%, 20% and 30% for both α and β.
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An outer loop of cross-validation is used to evaluate RMSE and an inner loop of CV scheme 
for method selection is performed in each training set of the outer loop).
Figure 4 shows scatter plot of RMSE performance comparing FBMG and CC in Scenario I 
(Figure 4a; α = 50% missing gene expression) and FBMM and CC in Scenario II (Figure 4b; β 
= 50% missing methylation) in 50 independent simulations. In Scenario I,FBMG generally has 
smaller RMSE than CC in small sample sizes (N = 50, 100, 200). But for N = 500, RMSE of 
FBMG becomes slightly larger than CC on average. For missing methylation in Scenario II, 
FBMM performs better than CC at N = 50 but gradually becomes worse than CC at N = 100, 
200 and 500. We applied the CV scheme in each simulation to determine whether imputation 
should be performed or not. Simulations shown by circles represent correct decisions (i.e. CV 
scheme decides to impute and the RMSE of imputation is indeed smaller than RMSE of CC or 
vice versa) and cross represents incorrect decision. The result shows universally high accuracy 
of CV scheme decision. When the decision is wrong, imputation and CC RMSEs are close to 
each other (near the diagonal line) and the incorrect decision only minimally impacts the 
outcome prediction. Figure 4c shows box plots of RMSE generated from different approaches 
(CC, FBMG, FBMM , FBMGM , CV) for Scenario III (α = β = 25%). At N = 50, FBMG and 
FBMGM both perform well and CV generates similar small RMSE. When N increases to 500, 
FBMGM becomes much worse and CC performs slightly better than FBMG. Again, the CV 
scheme makes mostly correct decision and thus generates small RMSE close to the lowest. In 
conclusion, the simulation results indicate effectiveness of the CV scheme in determining the 
best strategy of whether and how to impute when encountering missingness in multi-omics 
data.
2.5 REAL APPLICATION
2.5.1 Data and approach
We apply the proposed full Bayesian model with missingness to 460 children asthma nasal 
epithelium samples obtained from asthma study at Children’s Hospital of Pittsburgh, with 
complete DNA methylation data from Illumina 450k chips and RNA-Seq gene expression
29
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Figure 4: Model prediction performance of CV scheme.
a-b) In missing Scenario I (α = 50%, β = 0) and Scenario II (α = 0, β = 50%), scat-
ter plot of RMSEs between two methods are shown, where circle means cross-validation
scheme generates correct decision, and cross means mistakes. Sample size N varies from
50, 100, 200, 500. c) Box plot of RMSE of different methods and CV selection scheme in
Scenario III (α = β = 25%).
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data. All data were preprocessed with standard procedures and bioinformatics tools. We
used M-value for methylation level for better model fitting. The RNA-seq gene expression
counts were transformed to TPM (transcripts per million), a continuous value also more
valid for the model assumptions. We filter out genes with small mean expression level
(< 130.41) or small standard deviation (< 23.83) to obtain K = 1, 000 genes for the analysis.
We then select methylation sites matched to these 1,000 genes. Since some genes have
many corresponding methylation sites, we perform principal component analysis (PCA) to
identify the top eigen-methylation sites as input to the model. We take no more than
3 PCs per gene or less than 3 PCs that explain at least 75% variation. This generates
J = 2619 eigen-methylation features for the analysis. The PCA analysis reduces redundant
(highly correlated) information in methylation sites and independence of eigen-methylation
features fits the model assumptions well. Similar to simulation, we generate three scenarios
of missingness: (I) α = 50%, (II) β = 50%, (III) α = β = 20%. For each scenario, we repeat
50 times.
Serum Immunoglobulin E (IgE) level is a primary clinical outcome in children asthma
studies. We take log-transformed IgE level as our clinical outcome, and age and gender as
clinical variables. Together with the gene expression and methylation PCs, we run our model
with full data and three scenarios of missingness to compare complete case approach (CC)
and full Bayesian model with missingness (FBMG, FBMM and FBMGM).
2.5.2 Outcome prediction and feature selection
Table 2 shows the RMSE of outcome prediction from complete case analysis and FBMs.
When 50% samples have missing gene expression (Scenario I), FBMG had reduced RMSE
compared to CC (dropped from 43.34.19 to 36.04). In contrast, FBMM had inflated RMSE
compared to CC when 50% of missing methylation (51.59 compared to 39.54 in Scenario II).
When gene expression and methylation both missed 20% of samples (i.e. 40% of samples had
missing values in Scenario III), FBMG had the smallest RMSE (38.71) compared to FBMGM
(46.15), FBMM (54.23) and CC (39.09). Our CV scheme performed the automatic selection
of whether and how to impute, and the RMSE was always close to the best (I: 36.61, II: 41.09
31
Table 2: RMSE (S.E.) of different methods
Methods Scenario I Scenario II Scenario III
CC 43.34 (5.33) 39.54 (6.85) 39.09 (5.43)
FBMG 36.04 (4.73) 38.71 (5.73)
FBMGM 46.15 (4.74)
FBMM 51.59 (6.71) 54.23 (4.50)
CV 36.61 (3.78) 41.09 (6.17) 40.62 (7.36)
and III: 40.02). Figure 5a shows scatter plot or box plot of RMSEs of different methods in
all three Scenarios. Similar to the simulation result, CV scheme mostly selected the best
method and the mistakes were near the diagonal line with little predictive impact.
Unlike in simulation, no underlying truth is available for real data and thus calculation of
AUC is not possible. Figure 5b treats the predicted outcome from full data as the surrogate
of underlying truth and compare feature selection from each method with the surrogate
(i.e. x-axis shows the same number of features selected by the designated method and full
and y-axis demonstrates the overlap between the two). A curve with higher overlap shows
better similarity of feature selection with the surrogate, an indication of better performance.
Similar to the RMSE result, FBMG performed better than CC in Scenario I, CC better than
FBMM in Scenario II, and FBMG and CC performed better than FBMM and FBMGM in
Scenario III. CV scheme performs close to the best. All results from this real application are
largely aligned with our observations in simulation studies.
We next investigate whether feature selection from the imputation methods or method
selected by CV scheme represent better functional annotation in a biological sense. We
obtained the top 200 genes from feature selection of each method by posterior probability
order and then performed pathway enrichment analysis by one-sided Fisher’s exact test. We
collected 2,467 pathways from four pathway databases (KEGG, Reactome, Biocarta and
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GO) with the restriction of pathway size between 10 to 500. The enrichment p-values were 
then adjusted for multiple comparisons by Benjamini-Hochberg procedure. We found 27 
enriched pathways from the full data analysis under FDR=1%. We used these 27 pathways as 
a surrogate of gold standard to benchmark functional annotation performance of each method. 
Figure 6 shows box-plots of the minus log-transformed p-values from pathway enrichment of 
the 27 pathways in each method. As expected, FBMG had better p-value significance 
distribution than CC in Scenario I. In Scenario II, CC performed better than FBMM . FBMGM 
and FBMG outperformed CC in Scenario III. The CV scheme automatically determined 
whether and how to impute, and it always perform close to the best in each scenario.
2.6 DISCUSSION
Integrative analysis of multi-level omics data brings unique insights to the modulating re-
lationship between different types of omics data. Feature selection and model prediction are 
two important goals in multi-omics integration, which empowers discovery of disease-
associated biomarkers, survival prediction, and risk assessment. Several methods have been 
developed to fulfill these goals, including iBAG using a two-layer Bayesian hierarchical model 
to discover both association between genes and clinical outcome, and that between gene and 
upstream regulators. However, none of these methods are able to handle the potential large 
proportion of missing data in the data integration. In this paper, we propose a full Bayesian 
model with missingness (FBM) inspired by iBAG model, to jointly perform feature selection, 
model prediction, and missing data incorporation. In addition to the mechanistic model and 
clinical model originally proposed by iBAG, FBM includes a third layer of missingness model 
to incorporate samples with missingness. The flexibility of Bayesian hierarchical modeling and 
Gibbs sampler technique enables us to jointly model association among data and infer 
parameters in all three layers of models together. The Laplace (double exponential) prior 
initially used in iBAG could not realize exact feature selection. FBM applied spike-and-slab 
prior for more effective feature selection and allows Bayesian FDR control. We demonstrated
outcome prediction and feature selection performance of FBM using extensive simulations.
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Figure 5: Model prediction and feature selection of CV scheme in real data.
a) scatter plot of RMSEs between two methods are shown, where circle means cross-validation 
scheme generates correct decision, and cross means mistakes. b) The number of overlapped 
genes (features) selected by each methods compared with full asthma data. On x axis is the 
top number of genes selected by each method.
From the extensive simulations, we then further realized that imputation is not always 
favored over complete case analysis. For example, in high dimensional genomic data anal-
ysis, when missingness exists in upstream regulators (i.e. methylation), uncertainty will be 
increased to impair final inference. When the missing proportion is relatively small and the
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Figure 6: Pathway analysis similarities between methods with full data.
Compare different methods for the −log10(p) value of the top 27 pathways taken from full
data with q-value <0.01.
sample size is large (i.e. signal is strong), complete case analysis also often outperforms
FBM. To decide the best handling of data with missingness, we proposed a self-learning
cross-validation decision scheme. Previously, we have developed a similar self-training se-
lection scheme for selecting the best microarray missing value imputation method and its
downstream biological impact (Brock et al., 2008; Oh et al., 2011). In both simulation and
the childhood asthma application, we showed superior performance of the CV scheme in
prediction outcome and feature selection.
While Bayesian hierarchical model allows complex parameter structures, it also comes
with a computational cost when using conventional inference approaches such as Metropolis-
Hasting or its special case, Gibbs sampling. In FBM, fast Gibbs sampling was applicable
using conjugate priors and the convergence was generally fast (B=2000). We have optimized
the R code using C++ with Rcpp package. The computing takes 90 minutes for a reasonably
large dataset with N = 500 samples, K = 1000 genes, J = 2000 methylations and B = 2000
MCMC iterations using a regular computer with 1 Intel Xeon CPU (2.40 GHz). Since the
computation burden grows linearly with sample size, feature size and number of iterations,
applying FBM with parallel computing could be a solution to substantially speed up comput-
ing and allow routine omics applications. An R package, data and source code to replicate
all results in this paper are available on GitHub (https://github.com/CHPGenetics/FBM).
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3.0 INCORPORATING LINKAGE DISEQUILIBRIUM AND
IDENTITY-BY-DESCENT INFORMATION TO IMPROVE GENOTYPE
CALLING FROM FAMILY-BASED SEQUENCING DATA
3.1 INTRODUCTION
Next generation sequencing (NGS) technologies has greatly facilitated the discovery and de-
tection of genetic variants, serving as fuels for further downstream analysis. For instance, the
genome-wide associate studies (GWAS) have discovered thousands of associations between
a variety of traits and diseases and single nucleotide polymorphisms (SNPs).
One key first step in NGS downstream analysis is the inference of genotypes given the raw
sequencing reads or another preliminary inference. This inference step is ordinarily called
genotype calling or genotyping. While genotype calls with sufficient accuracy for further
downstream analysis could be achieved by a redundant sequencing on relatively limited
sample size, or referred as deep sequencing, many have proven that for a given budget,
sequencing more samples with shallower depth, facilitated by likelihood-based LD-aware
methods, could greatly improve genotype calling accuracy (Li et al., 2011; Li and Stephens,
2003). For example, a deep sequencing with 30X read depth typically results in > 99%
overall genotype calling accuracy. Yet Li et al. (2009) showed that, under similar budget,
with the help of LD-aware genotyping methods, sequencing more individuals with read depth
as low as 2X achieved higher overall genotyping accuracy compared with deep sequencing less
individuals with 30X read depth (Li et al., 2011). This low-coverage large-cohorts sequencing
strategy has been widely adopted by genotype profiling projects, including UK10K project
and 1000 Genome Project. Correspondingly, genotyping methods designed for low-depth
sequencing are emerging. These methods either using dynamic programming technique like
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hidden Markov model (HMM) or EM algorithms, and are largely based on the LD pattern
recognition (Li et al., 2011, 2010; Browning and Browning, 2016; Chen et al., 2013; Chang
et al., 2016; Zhou and Whittemore, 2012).
On the other hand, family-based sequencing projects have their unique strengths com-
pared to unrelated population sequencing in, for example, detecting rare causal variants
(MAF < 1%), understanding parent-of-origin effects, and studying Mendelian disorder.
When sequencing from the family-based data, genotype calling could be further improved
by leveraging partially the pedigree information, or identity-by-descent (IBD) information,
in the statistical models (Li et al., 2015; Chen et al., 2013; Chang et al., 2016; Zhou and
Whittemore, 2012). For example, Chen et al. (2013) has benchmarked that by considering
trio parent-offspring constraints imposed by Mendelian inheritance, the genotype calling in
trio family-sequencing data is improved, compared with previous LD-based methods ignoring
the family constraints. Chang et al. (2016) extended the idea to general family structures
by breaking down pedigree to trios and achieved higher genotyping accuracy in such family
structures compared with its predecessor. And Zhou and Whittemore (2012) took both fam-
ily constraints and LD constraints into account in a EM-algorithm based likelihood model,
and showed the gain in genotyping accuracy by leveraging both LD and pedigree information.
Yet this program is not publicly available, and compared with hidden Markov models, EM
algorithm is not a mainstream solution for genotyping problems. Li et al. (2015) proposed a
method that uses inheritance vectors (IV) to describe and IBD patterns, therefore improve
genotype calling in family-based data for especially rare variants. Yet an effective, accurate,
and computationally feasible method to comprehensively incorporate both LD and pedigree
constraints for genotype calling is still lacking.
Here we propose our HMM-based model, inspired by aforementioned existing methods,
to improve genotype calling in family-based sequencing data. In our model, we jointly
infer the genotyping likelihood in a family with both LD patterns and IBD patterns consid-
ered. We benchmarked the performance of our method using both synthetic data (real data
simulation using 1000 Genome Project) under different sequencing scenarios with varies of
sequencing depth (2X-10X) and per-base error rate (Phred score 20 and 30). For comparison,
we also benchmarked a few of the most popular or best performing methods, GATK, Bea-
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gle4, FamLDCaller, Polymutt2. The results show that our method achieves highest overall
genotype calling accuracy, and the improvement under some scenarios could be up to 50%.
The main gain in genotyping accuracy happens in rare (MAF < 1%) and moderately rare
allele (MAF 1-5%). We also apply our method to a family-based whole exome sequencing
dataset from anorexia cohort, collected in Kartini Clinic in Portland, Oregon, with 74 indi-
viduals within 26 pedigrees. We randomly subsample sequencing reads to mimic shallower
sequencing scenarios to the average sequencing depth from 4X to 9X. The results showed
that LDIV has the highest genotyping accuracy and relatively low Mendelian error rates.
3.2 METHODS
Similar to Li et al. (2015), we start introducing genotype inference by assuming the ith
genome position is covered by N mapped A, C, G, T bases w/ counts NA, NC , NG, and NT .
Base error rate ei correspond to mapped base calls bi ∈ {A,C,G, T} indicate this location
is incorrectly called. Ri to denote all the base calls, which are the observed read data, and
Gi, the hypothetical true genotype. Due to sequencing errors and allele dropout, a total of(
4
2
)
+ 4 = 10 genotypes are possible.
We have two assumptions 1) all base calling errors are independent; and 2) for heterozy-
gous genotypes, we assume each base originates from either one allele with equal probabilities.
E.g. P (A|AC) = P (C|AC) = 0.5.
Base bi is either A or C then P (bi|AC) = 12(1 − 2ei/3) and otherwise P (bi|AC) = ei/3.
Then the GL (genotype likelihood) of genotyp AG combining all bases is
P (Ri|AC) =
NA+NC∏
k=1
1
2
(1− 2ek/3)
N−NA−NC∏
k=1
(ek/3)
Then we can calculate all possible GL by traversing all 10 genotypes.
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3.2.1 Leveraging LD Information with Hidden Markov Model
Li et al. (2011) developed an LD-based computational method to increase genotyping accu-
racy with linkage disequilibrium information. Chen et al. (2013) and Chang et al. (2016)
extended that methods to include partial information from the family structure. Those
methods are essentially describing the entire sequenced haplotypes as if they are constructed
by mosaics from multiple other reference haplotypes, either from other family members, or
from outside reference panels. First we define P (Gi|Hi) as the probability of an underlying
true genotype Gi given mosaic chromosome Hi, the state in HMM. To calculate this we
define T (Gi) or T (Hi), the number of variant alleles in Gi or in the reference haplotypes
indexed by Hi. To be specific, genotype {0,0}, {0,1}, {1,0}, and {1,1} correspond to T =
0,1,1,2, respectively.
P (Gi|Hi) =

(1− εi)2 {T (Hi) = 0 or T (Hi) = 2} and T (Hi) = T (Gi),
εi(1− εi) {T (Hi) = 0 or T (Hi) = 2} and |T (Hi)− T (Gi)| = 1,
ε2i {T (Hi) = 0 or T (Hi) = 2} and |T (Hi)− T (Gi)| = 2,
(1− εi)2 + ε2i T (Hi) = 1 and T (Hi) = T (Gi),
2εi(1− εi) T (Hi) = 1 and T (Hi) 6= T (Gi)
where εi is the mosaic error rate representing cumulative effects of mutation and gene con-
version. Together P (Ri|Gi) and P (Gi|Hi) give us:
P (Ri|Hi) =
∑
Gi
P (Ri|Gi)P (Gi|Hi) (3.2.1)
This is because we have:
P (Ri|Hi) =
∑
Gi
P (Ri, Gi|Hi) =
∑
Gi
P (Ri|Gi, Hi)P (Gi|Hi)
P (Ri|Gi, Hi) = P (Ri|Gi)
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The above equation stands because given genoypes alone we have the probabilities of reads,
regardless of the reference states. I.e., reads and states are conditional independent given
genotypes.
Or in notations in the Thunder, equation (3.2.1) is written as:
P (Ri|Hi) ∝ P (Ri, Hi)
The above could be written out as the factorization of forward and backward variable in
HMM.
Then we calculate the transition probability in HMM P (Hi+1|Hi) as:
P (Hi+1 = (w, v)|Hi = (x, y)) =
θ2i /H
2 x 6= w and y 6= v
(1− θi)θi/H + θ2i /H2 {x = w and y 6= v} or {x 6= w and y = v}
(1− θi)2 + 2(1− θi)θi/H + θ2i /H2 x = w and y = v
where (x, y) and (w, v) denote indexes for the reference haplotypes at location i and i+ 1; θi
denotes the mosaic transition rate and H the number of reference haplotypes Then P (Hi|R)
can be calculated using forward and backward (or called left and right) probabilities following
HMM conventional algorithms such as Baum’s forward-backward sampling algorithm. And
our final goal, P (Gi|R), can be calculated as following:
P (Gi|R) =
∑
Hi
P (Gi|Hi)P (Hi|R) (3.2.2)
by looping through all reference mosaics Hi. Similar to equation (3.2.1), the equation (3.2.2)
stands because we have:
P (Gi|R) =
∑
Hi
P (Gi, Hi|R) =
∑
Hi
P (Gi|Hi,R)P (Hi|R)
and that:
P (Gi|Hi,R) = P (Gi|Hi)
assuming genotypes and reads are conditional independent given states.
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3.2.2 Leveraging IBD Information by Inheritance Vector
Li et al. (2015) proposed Polymutt2 seeking to improve genotype calling accuracy from the
perspective of using IBD information to fully account for information from family structure.
Assuming we start with ordered f founders and n non-founders, with M variants. Defining
binary inheritance vector (IV) at variant i : Ii = (p1,m1, ...pn,mn) where pj and mj indi-
cating the transmission of paternal and maternal allele. 0, 1 indicates grand-paternal and
grand-maternal allele being transmitted. There are total of N = 2n possible IVs, because
half of the original N = 22n possible IVs are redundant considering that we may simply
flip each founder’s haplotype. Let vk, k = 1, ...N denotes the kth IV; Ri and Gi being all
reads and genotype at variant i, Rij and Gij = (Afather, Amother) being reads and genotype
of person j at variant i.
The likelihood of reads across M variants is:
P (R) =
∑
I1
...
∑
IM
P (I1)
M∏
i=2
P (Ii|Pi−1)
M∏
i=1
P (Ri|Ii)
The initiation part is uniform across all possible IVs; transition part is calculated based on
recombination rate; and the emission part is calculated as:
P (Ri|Ii) =
∑
Gfounders
f+n∏
j=1
P (Rij|GijIi)
f∏
j=1
P (Gij) (3.2.3)
Becaus we know genotype of all family members as long as the IV and genotype of founders
are given. The prior probability P (Gij) can be acquired from external sources or estimated
assuming HWE holds.
One key goal here is to infer posterior distribution of the IVs, i.e. P (Ii|R). We use
forward-backward procedure in HMM, and the posterior probability of vk at variant i is:
P (Ii = vk|R) = αi(k)βi(k)∑N
k=1 αi(k)βi(k)
(3.2.4)
From the marginal distribution we can find the inheritance vector with maximum posterior
probability at variant i, denoted as Imargi . But this only maximize likelihood marginally at
variant i. So we use Viterbi algorithm to infer a inheritance vector that achieve maximum
likelihhod globally for all variants, denoted as Ibesti .
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Then for the family we have our posterior likelihood as:
P (Gi1, ...Gi(f+n)|Ibesti ,Ri) =
P (Ri|Gi1, ...Gi(f+n), Ibesti )P ((Gi1, ...Gi(f+n)|Ibesti ))
P (Ri|Ibesti )
=
∏f+n
j=1 P (Rij|Gij, Ibesti )
∏
Gfounderi
P (Gfounderi )
P (Ri|Ibesti )
(3.2.5)
3.2.3 Jointly Leveraging LD and IBD: LDIV
Here we propose our new method to jointly using LD and IBD information, which is expected
to give us a more accurate overall (especially on not-rare variants) genotype estimation. A
very generic form of fusing the two information is to be able to infer genotype conditional on
both, or either, hidden states H (reference haplotypes) and inheritance vectors I. First we
consider an individual at variant i, be reminded that our final goal is to get: P (Gi|R). We
assume that inheritance vectors and reference states are independent from each other given
reads, i.e. P (Hi|Ii,R) = P (Hi|R), though this is not rigorously the case.
First in a certain family, for variant i:
P (Gi1, ..Gi(f+n)|Ibesti , Hi1, ..Hif ,Ri) =
∏f+n
j=1 P (Rij|Gij, Ibesti )
∏f
j=1 P (Gij|Hij)
P (Ri|Ibesti , Hi1, ..Hif )
(3.2.6)
The above equation stands because 1) given inheritance vector Ibesti we are able to pass
the states and genotypes to each individual; and 2) given genotypes, reads and states are
conditionally independent, i.e.:
P (Ri|Gi1, ..Gi(f+n), Ibesti , Hi1, ..Hif ) =
∏f+n
j=1 P (Rij|Gij, Hij, Ibesti ) =
∏f+n
j P (Rij|Gij, Ibesti )
Similarly, we have: P (Gi1, ..Gi(f+n)|Ibesti , Hi1, ..Hif ) =
∏f
j=1 P (Gij|Hij)
For the denominator, similar to (3.2.3) we have
P (Ri|Ibesti , Hi1, ..Hif ) =
∑
Gfounders
f+n∏
j=1
P (Rij|Gij, Ibesti )
f∏
j=1
P (Gij|Hij) (3.2.7)
The likelihood (3.2.3) and (3.2.7) differs only in the prior, which is the way founders’ geno-
types are inferred. Rather than a plain P (Gij), LDIV incorporates the LD information by
using states to correct possible errors of founder’s genotype calls, i.e. P (Gij|Hij).
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…a) b)
n non-founders
Figure 7: Family structures.
a) nuclear families, family type 1-4 corresponds to n ∈ [1, 4]; b) family type 5.
Plugging likelihood (3.2.7) into (3.2.6), we have:
P (Gi1, ..Gi(f+n)|Ibesti , Hi1, ..Hif ,Ri) =
∏f+n
j=1 P (Rij|Gij, Ibesti )
∏f
j=1 P (Gij|Hij)∑
Gfounders
∏f+n
j=1 P (Rij|Gij, Ibesti )
∏f
j=1 P (Gij|Hij)
(3.2.8)
This is the final posterior likelihood. Note that the only differece between posterior
likelihoods (3.2.5) and (3.2.8) lies in the prior, where Polymutt2 uses P (Gij), LDIV will use
P (Gij|Hij) instead. After we inferred Ibesti for i = 1, ..M , we take it as known. And for each
states we will use above likelihood to update genotypes.
3.3 RESULTS
3.3.1 Simulation Scheme
To evaluate the performance of our method, we simulated genotypes from 150 families with
5 different family structures, including nuclear family with one up to four offspring, as well
as 3-generation family with 5 non-founders (Figure 7). Each of our simulated data family
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structure contains 30 families with one of the family structure. We generated approximately
10,000 sites from 1 million base pair length of haplotypes using 1000 Genomes Project data,
mimicking the LD pattern and IBD pattern. Genotypes are sequenced at depth 2X, 6X
and 10X to better represent the need in reality when only lower to middle depth sequenced
data are provided for genotype calling. The per base error rate is set as 0.01 and 0.001,
corresponding to Phred scaled based quality of Q20 and Q30, respectively.
Some of the methods including LDIV allow incorporating outside reference files to en-
hance genotyping performance by borrowing information from high confident calls. These
reference files usually are usually in variant calling format (VCF), with high percentage of
overlapping variants as the VCF files to be called, and are genotyped with high quality.
Some real world reference files could be obtained from large sequencing projects like 1000
Genome projects. Here we adopt similar simulation scheme as aforementioned simulation
data for simulating reference files, except that the source haplotypes for simulation data and
reference data have no overlaps, mimicking the real world scenarios where individuals to be
genotyped are not the same as the individuals from public genotyping references databases,
although it is recommended that they are from same population.
We compare our method with other popular genotype inference tools including FamLD-
Caller, Polymutt2 and Beagle4 with recommended or default parameter settings on all sim-
ulated family-based sequencing data. To be specific, we set number of states at 40 with
30 rounds for FamLDCaller and our method LDIV; we set r2 parameter as 0.2 and mini-
mum average depth as 2 for both Polymutt2 and LDIV; we set phasing iterations as 5 and
imputation iteration as 5 for Beagle as suggested by their manuscript.
3.3.1.1 Benchmarking for Evaluation The most important benchmarking criteria is
the genotyping accuracy. We compared all methods for genotype accuracy across all variants,
as well as heterozygote sites only. And to gain a more in-depth view of the strengths and
weakness of tools.to gaine also divided heterozygote sites markers by minor allele frequency
(MAF) as representation of rare variants (MAF < 1%), moderate variants (MAF 1-5%), and
common variants (MAF > 5%). Furthermore, we provided comparisons of another important
criterions in family sequencing genotyping, the Mendelian error rates and phasing accuracies.
44
Taking the genotype from 1000 Genome project haplotypes as truth, the genotyping accuracy
is defined as the number of correctly called loci divided by the total number of loci. And
phasing accuracy is defined as the number of correctly phased loci divided by total number
of correctly genotyped loci.
3.3.2 Simulation Results
3.3.2.1 Genotyping Accuracies Simulation results generally showed two trends (Fig-
ure 8-13, Supplementary Figure 23-25, Supplementary Table 15-19, 20-24). First is that for
all methods, the overall genotyping accuracies increase when the sequencing depth increase
(from 2X to 10X), as well as when the per-base error rate decreases (from 0.01 to 0.001).
Another trend is that, when available, taking outside reference panels will generally increase
genotyping accuracies. And this effect is most significant when sequencing depth is low,
and per-base error rate is high, because the less information a sequenced individual can pro-
vide, the more boost in performance we expect to see when the same outside high quality
information is borrowed.
The simulation results show the overall superior performance of LDIV compared to all
other methods in overall genotype calling accuracy with or without reference files (Figure
8, 11, Supplementary Figure 23) for almost all family types. In very informative families
like family type 4 (Figure 8) for some most contrasting scenarios for example, sequencing
depth=6X, per-base error rate=0.01, LDIV without reference files has any overall genotyping
accuracy of 99.93%, LDIV with reference files increases the accuracy to 99.97%; in contrast,
the second best method in this case is FamLDCaller, which renders accuracies of 99.87%
without reference file, and 99.92% with reference files. The largest reduce in genotype calling
error rates are 46.2% without reference, and 62.5% with reference. When family structures
are less informative, i.e., with less siblings and more complicated family structures which may
hinder the construction of inheritance matrices (Figure 11), LDIV still achieves better overall
genotyping accuracies in most of the cases, but the improvement is less than significant.
A further investigation of genotyping accuracy in only the heterozygote sites (Figure
9) show similar pattern as overall genotyping accuracy, LDIV is still the best performing
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method, especially with reference panel included, which is as expected. For some of the
most contrasting scenarios, the improvement in genotyping error rates of LDIV compared to
the second best methods can be up to 60% with or without reference panels.
Methods using LD and IBD information is supposed to have different performance for
rare and common SNPs, for example, methods leveraging LD information with the help of
reference panel is supposed to be preferable for common SNPs, as those variants could be
more likely found in the population where reference panel is sampled from. So we also look
into the performance of different methods for rare (MAF < 1%), moderate (MAF 1-5%),
and common (MAF > 5%) SNPs separately (Figure 10, 13). In almost all cases across all
rarities, LDIV shows superior accuracy compared to other methods with or without the use
of reference panel. This is because LDIV tend to weigh more on IBD information when
family information is abundant (e.g. more siblings involved) and minor allele frequency is
low; and tend to weigh on LD information when reference panel is provided.
3.3.2.2 Phasing Accuracies We then compare phasing accuracies of different methods,
and we found that including reference files will usually, but not always increase the phasing
accuracies (Table 4, Table 6, Supplementary Table 14). Although LDIV is not designed
specifically for phasing purpose, its phasing accuracies are on a par with most of current
methods. For example in family 5, with sequencing depth 2X, per-base error rate 0.01, LDIV
will have phasing accuracy of 95.98% with reference files, and 97.03% without reference
files, while the best method in this scenario is Beagle4, with 99.16%, and the worst is
Polymutt2, with 86.12%. This is because Polymutt2 will rely solely on inheritance matrices
for inference, following exact Mendelian law, and thus fail to take into account of similarity
between individuals not related but might be from same population. Thus we can see
that LD-aware methods is advantageous generally in phasing tasks compared to IBD-aware
methods. Therefore, since LDIV takes reference from both IBD and LD information, its
phasing performance is expected to be between two sets of methods.
3.3.2.3 Mendelian Error Rates Last but not least, we compare each methods perfor-
mance in following Mendelian’s Law by summarizing Mendelian error rates. Methods that
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Figure 8: The overall genotyping accuracy for nuclear family type 4.
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Figure 9: The genotyping accuracy on heterozygote sites for nuclear family type 4.
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Figure 10: The genotyping accuracy on heterozygotes sites by MAF for nuclear family type
4.
Table 3: Mendelian error rate for family type 4
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 23.37 16.15 6.008 0 9.983 4.608
2X BE30 21.33 16.23 5.692 0 7.458 4.25
6X BE20 5.067 3.525 1.358 0 0.7167 0.6167
6X BE30 5.017 3.025 1.25 0 0.8333 0.5667
10X BE20 2.458 1 0.4583 0 0.1583 0.15
10X BE30 1.833 0.825 0.5417 0 0.275 0.3333
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Table 4: Phasing accuracy for family type 4
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.99 0.972 0.9932 0.8785 0.954 0.9691
2X BE30 0.992 0.9773 0.9936 0.8966 0.9612 0.9694
6X BE20 0.9985 0.9964 0.9987 0.9562 0.9931 0.9692
6X BE30 0.9987 0.9976 0.9989 0.9771 0.9956 0.9698
10X BE20 0.9994 0.9993 0.9994 0.9832 0.9988 0.9774
10X BE30 0.9995 0.9996 0.9996 0.9941 0.9991 0.9806
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Figure 11: The overall genotyping accuracy for nuclear family type 5.
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Figure 12: The genotyping accuracy on heterozygote sites for nuclear family type 5.
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Figure 13: The genotyping accuracy on heterozygotes sites by MAF for nuclear family type
5.
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Table 5: Mendelian error rate for family type 5
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 21.84 13.11 7.372 0 10.98 6.856
2X BE30 19.52 13.41 4.789 0 9.6 4.511
6X BE20 5.75 1.972 1.161 0 0.7444 0.7444
6X BE30 4.95 1.644 0.7611 0 0.7444 0.7056
10X BE20 2.233 0.55 0.3389 0 0.06667 0.1889
10X BE30 1.728 0.3556 0.1444 0 0.07222 0.1444
Table 6: Phasing accuracy for family type 5
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.9916 0.9705 0.9897 0.8612 0.9598 0.9703
2X BE30 0.9933 0.9726 0.9925 0.8563 0.9651 0.9748
6X BE20 0.9985 0.9961 0.9983 0.9767 0.9917 0.9812
6X BE30 0.9987 0.9952 0.998 0.9834 0.9933 0.9731
10X BE20 0.9994 0.9991 0.9994 0.988 0.9974 0.9811
10X BE30 0.9995 0.9988 0.9996 0.997 0.9983 0.9781
53
are established purely based on the inferred inheritance matrices like Polymutt2 will have
no Mendelian error rate by theory (Table 3, Table 5, Supplementary Table 13). And since
LDIV is built partially on inferred inheritance matrices, it has an edge over methods that ig-
nored inheritance structures like Beagle4. And since FamLDCaller only consider trio family
substructure inside a more complicated family, its performance will be better than Beagle4,
yet not as good as LDIV. And lastly, we also see that including outside phased reference files
will lower the Mendelian error rates. An example to illustrate all above observations is that
in family type 4, with sequencing depth 2X and per-base error rate 0.01, Beagle 4 has most
Mendelian error, 23.37 per individual, while Polymutt2 has 0. LDIV performed the best
among LD aware methods, with 9.983 Mendelian errors per individual without reference,
and 4.608 with reference; FamLDCaller performed third best, with 16.15, and 6.008 errors
per sample without, and with reference, respectively.
3.4 REAL STUDY
3.4.1 Data description and preprocessing
We used the whole exome sequencing (WES) data collected in Kartini Clinic in Portland Ore-
gon. The sequencing was conducted by capture kit Agilent version 4.0 on HiSeq 2000, funded
by Klarman Family Fundation. The samples are from anorexia cohort with all anorexia pa-
tients and family members sequenced, consisting 74 individuals within 26 pedigrees. The
family structures vary from unrelated individual, trio nuclear family, to nuclear family with 4
offspring. The average sequencing depth is ∼ 15X. We take chromosome 22 for the purpose
of demonstration in our real study, consisting of 80k variants. We followed the GATK best-
practice procedure for all data preprocessing. Firstly, among the variants, only those that
are deeply sequenced are taken as the ground truth for future comparison. To be specific,
the original processed and genotyped data in variant calling format are filtered by minimum
average sequencing depth greater than 20X, with 5k variants left, and their genotype calls
as truth. Secondly, we do random subsampling on the original BAM files, with subsample
54
l0.
94
5
0.
95
0
0.
95
5
0.
96
0
0.
96
5
0.
97
0
0.
97
5
G
en
ot
yp
in
g 
Co
nc
or
da
nc
e
10
\%
l
0.
96
5
0.
97
0
0.
97
5
0.
98
0
0.
98
5
G
en
ot
yp
in
g 
Co
nc
or
da
nc
e
30
\%
l
0.
96
5
0.
97
0
0.
97
5
0.
98
0
0.
98
5
G
en
ot
yp
in
g 
Co
nc
or
da
nc
e
50
\%
Figure 14: The overall genotyping accuracy for real data.
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Figure 15: The genotyping accuracy on heterozygote sites for real data.
Table 7: Mendelian error rate (per family) for real data
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
10% 455.9 275.8 206.6 0 338.3 190.1
30% 1105 864.4 464.7 0 1039 430.5
50% 1929 1441 666.8 0 1755 633.9
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proportion of 10%, 30% and 50%, mimicking shallower sequencing experiments, resulting in
subsampled datasets with average sequencing depth of 4X, 6X, and 9X, respectively. The
subsampled VCF files are then used as input for each methods we aim to compare as in
simulation studies. Similarly, benchmarking criteria are overall genotyping accuracies, geno-
typing accuracies for heterozygotes only, and Mendelian error rates. We didn’t phase original
data, so no phasing accuracy is compared in real study. And by the sample size limitation,
the number of rare variants (MAF < 1%) after filtering by minimum average depth or sub-
sampling are not sufficient for comparison, so we didn’t separate variants by MAF in our
evaluation. The reference panel in this study is taken from chromosome 22 of 1000 Genome
Project Phase 3 data, with 2504 individuals in 26 populations.
3.4.2 Real study results
3.4.2.1 Genotyping accuracies We first compare the genotyping accuracy on the over-
lapped variants in truth and subsampled data for methods as in simulation studies. As ex-
pected, the genotyping accuracies increase as sequencing depth increases, which is induced
by the increasing subsampling percentage in this study (Figure 14, 15). And also we see,
when outside reference panel is used, generally the genotyping accuracy for both all vari-
ants and for heterozygotes only will increase. Furthermore, similar to simulation studies,
we see that with or without reference files, LDIV almost always outperform other tools in
terms of genotype calling accuracies. The main improve in genotyping occurs when com-
paring overall genotype calling accuracies, where for example for 4X sequencing depth data,
LDIV decreased genotype calling error rates by 23.3%, comparing the second best methods,
FamLDCaller.
3.4.2.2 Mendelian error rates We then proceed to compare Mendelian error rates
between methods. We found that LDIV is generally retaining decent Mendelian error rate.
For example for 4X data, LDIV without reference panel has 455.9 Mendelian errors per
family, which is more than FamLDCaller (275.8), but less than Beagle4 (338.3); while with
reference panels, LDIV has the least Mendelian errors (190.1) among LD-based methods
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(all but Polymutt2), while FamLDCaller has 206.6. Generally we found, among LD-based
methods, without reference panels, LDIV has less Mendelian errors than Beagle4, but more
than FamLDCaller. And as expected, IBD-based method, Polymutt2, achieves absolute 0.
3.5 DISCUSSION AND CONCLUSION
We proposed a statistical and computational method, namely LDIV, to improve genotype
calling accuracy in family-based next-generation sequencing data. Sequencing family data is
crucial in uncovering association patterns of rare inheritable diseases. Compared to current
genotype calling methods for family data, LDIV is advantageous in that it considers both
linkage disequilibrium patterns and Mendelian inheritance patterns. The LD patterns are
estimated either from samples within studies, or references including more deeply-sequenced
or confidently-called samples from larger cohorts, like 1000 Genome projects. On the other
hand, IBD patterns are estimated within each family. The inferences of both sets of patterns
are effectively done in hidden Markov models, making LDIV a two-hidden-Markov-models-
powered method. One possible improvement in the future could be sampling inheritance
vectors by their posterior probability and do majority vote to summarize IBD pattern, in-
stead of using the one and most likely inheritance vector Ibest. This is expected to make the
outcome more robust against uncertainty from IBD pattern inference.
LDIV with joint likelihood takes into account of both LD and IBD information, and
by balancing the two information, we are able to reach a higher genotype calling accuracy
across different rarity, with different family structures, and with or without external reference
genomes. In simulation studies, for some very informative families (Figure 8), in some
encouraging scenarios, LDIV will reduce genotype calling error rates comparing to the second
best method, up to 46.2% without reference, and up to 62.5% with reference. Although one
may argue that the accuracies are already high for both methods, when calling SNPs across
genome, this error rate will induce up to 10,000 wrongly called genotypes, considering the
total 10 million SNPs in human genome. And LDIV performs the best when family structure
is informative, i.e., with many siblings that could help increase confidence in the inference
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of inheritance patterns and share sequencing reads information across individuals, as well as
when reference haplotypes are available. Actually, the use of external reference is generally
encouraged in LDIV to improve genotype calling for variants of moderate to high minor allele
frequencies. Meanwhile, LDIV will weigh on more informative families to help genotype calls
on rare loci.
Similar to simulation studies, in real analysis, we found that LDIV is generally able to
achieve the highest genotyping accuracy for both all variants and for heterozygotes loci only.
Although the improvement is not as astonishing as in simulation studies where informative
family structures are used, the improvement in reducing genotyping discordance rate could
be up to 23.3% comparing LDIV to the second best method. And this advantage is especially
strong when sequencing depth is low, meaning that LDIV is able to meet the need of handling
data from cost-effective sequencing experiments.
LDIV will also balance Mendelian inheritance and phasing accuracy. As for simulation
studies, the Mendelian error rate of LDIV is decently low, although not as low as pure
Mendelian-inheritance-based methods like Polymutt2, which sacrifice genotype calling accu-
racy to achieve absolute Mendelian accuracy. As for phasing accuracy, LDIV is keeping a
fairly low switching error rates throughout all simulation scenarios in simulation studies. We
should also note that comparing phasing accuracy is disadvantageous for methods having
higher genotype calling accuracies, in this case, LDIV. Because the loci that are incorrectly
called will not incur a switch error, but only the loci correctly called will. Furthermore,
in real studies, LDIV will outperform Beagle4 without reference panel, and outperform all
other LD-based methods when reference panel is provided. Interestingly we found that the
high number of Mendelian error rates could be partially, apart from the small percentage
of multiple-sibling families in this dataset, responsible for the low genotype calling accuracy
of Polymutt2, which strictly follows Mendelian’s Law. And therefore, by balancing family
information as well as LD patterns, LDIV is able to achieve both high genotyping accuracy
and low Mendelian error rates.
In addition to the improvement in genotype calls by leveraging family and LD informa-
tion, several other methods are proposed to approach the optimization of genotype calling in
different angles. PhredEM is a method using EM algorithm to improve estimation accuracy
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of base call error rates13. Other methods seek to reduce bias in allele frequency estimation,
by either maximum likelihood method, or empirical Bayesian method. Similar to GATK19,
those methods can be used in bundle with LDIV to achieve overall best genotype calls. Ei-
ther these methods could use processed sequencing reads to make first round genotype calls,
which will be later refined by LDIV; or they may serve as a correction tools to provide less
biased estimations of base calling error rates and allele frequencies to LDIV for optimized
inferences.
LDIV is implemented efficiently in C++. And by using dynamic programming tech-
niques in inferences of hidden Markov models, LDIV is decently fast and feasible in terms
of memory usage and computation time on a regular server, even for whole exome and even
whole genome sequencing data. To better meet the need of smaller lab without rich compu-
tation power, especially with limited memory, we also provided a fully automated pipeline
for splitting variants to do genotype calls using LDIV according to available memory. LDIV
is freely available on both Github and https://sites.google.com/site/arkzhf9/home/ldiv, to-
gether with testing datasets, relevant pipelines, and user manuals with example starting
guide that is easy to follow for users with basic Linux command line knowledge.
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4.0 COMPARATIVE PATHWAY INTEGRATOR: A FRAMEWORK OF
META-ANALYTIC INTEGRATION OF MULTIPLE TRANSCRIPTOMIC
STUDIES FOR CONSENSUAL AND DIFFERENTIAL PATHWAY
ANALYSIS
4.1 INTRODUCTION
In a typical transcriptomic study, a set of candidate genes associated with diseases or other
outcomes are first identified through differential expression analysis. Then, to gain more in-
sight into the underlying biological mechanism, pathway analysis (a.k.a. gene set analysis) is
usually applied to pursue the functional annotation of the candidate biomarker list. The ra-
tionale behind pathway analysis is to determine whether the detected biomarkers are enriched
in pre-defined biological functional domains. These functional domains might come from one
of the publicly available databases such as Gene Ontology (GO) and the Kyoto Encyclopedia
of Genes and Genomes (KEGG). Three main categories of pathway analysis methods have
been developed in the past decade. The first method called ”over-representation analysis”
considers biomarkers at a certain DE evidence cutoff and statistically evaluate the fraction
of DE genes in a particular pathway found among the background genes. Without a hard
threshold, the second category ”functional class scoring” takes the DE evidence scores of all
genes in a pathway into account and aggregates them into a single pathway-specific statistics.
The third category ”pathway topology” further incorporates the information of inter-gene in-
teraction and their cellular location in addition to the pathway database (Khatri and Butte,
2012).
Many transcriptomic datasets have been generated with the rapid advances of high-
throughput genomic technologies in the past decade. Meta-analysis, a set of statistical
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methods for combining multiple studies of a related hypothesis, has thus become popular.
Few methods have been developed for the pathway meta-analysis so far (Huang et al., 2009).
Shen and Tseng (2010) developed two approaches of meta-analysis for pathway enrichment
by combining DE evidence at the gene level (MAPE G) or at the pathway level (MAPE P).
MAPE P, which performed meta-analysis on the pathway level to generate a combined evi-
dence score for each pathway. When multiple datasets for a common hypothesis are available
under different conditions (e.g., tissues or labs), it might also be interesting to detect path-
ways enriched consistently under all conditions (consensual pathways) and pathways enriched
solely in one condition but not in the others (differential pathways). One na¨ıve way is to
identify the enriched pathways in each study individually and manually check whether a
certain pathway is enriched in one or multiple studies. To the best of our knowledge, there
is currently no available statistical tool that can achieve this goal systematically.
One issue emerges with pathway analysis is the pathway redundancy. The large amount
of individual pathways identified can hardly infer the underlying biology directly due to this
issue. This kind of redundancy typically occurs in a regular pathway analysis since differ-
ent pathways may include many overlapping genes. Toolkit DAVID resolved this issue by
clustering pathways based on a kappa statistics representing the pathway similarity (Cohen,
1968). But the users still need to manually inspect every pathway in a cluster. Furthermore,
due to the long and vague pathway description, users can barely make solid conclusions from
the results.
In light of this, we proposed a framework of meta-analytical integration of multiple
transcriptomic studies for consensual and differential pathway analysis, wrapped in a tool
named Comparative Pathway Integrator (CPI). Our tool incorporates 24 databases, such
as MSigDB, GO, KEGG, or user-defined gene set lists, as reference of pathway analysis.
In order to identify both commonly and study-specifically enriched pathways, we applied
the adaptively weighted Fisher’s method, which is originally developed to combine p-values
from multiple genomic studies for detecting homogeneous and heterogeneous differentially
expressed genes. Clustering analysis based on the overlapping genes among enriched path-
ways is applied to remove the level of pathway redundancy. Subsequently, we developed a
text mining algorithm to automate the annotation of pathway clusters by extracting key-
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words from pathway descriptions, which also offers more statistically valid summarization
compared to leaving user exploring each pathway in a cluster manually and heuristically.
Lastly, CPI visualize the findings and provide users both text and graphical outputs for
intuitive while statistical solid presentation and easy interpretation. An R GUI package CPI
is available online to perform the analysis.
4.2 MATERIALS AND METHODS
4.2.1 Workflow of Comparative Pathway Integrator (CPI)
CPI is a comprehensive tool incorporating several widely accepted mature methods as well
as some novel algorithms/approaches. It is mainly composed of three steps (see Figure
16). The first step is meta-analytic pathway analysis, which include pathway enrichment
analysis and meta analysis. This step partially resembles the work of R package MetaPath.
While MetaPath focuses on detecting consensus expressed pathways, CPI will detect both
consensual and differentially expressed pathways, providing extra information on how the
patterns of pathway enrichment differ across studies. The second step is pathway clustering.
This step aims to reduce the redundancy of the pathways from normally hundreds of enriched
pathways to a few clusters of pathways. The results are more succinct and interpretable.
The third step is text mining based on the pathway names and descriptions to find keywords
characterizing the overall information of the cluster. A permutation-based statistical test is
provided to assess if a specific keyword significantly appear more than by chance. Without
this step, it would be difficult to identify the representative characteristics for each cluster
and users may still need to eyeball all the pathways in results since the step of clustering of
the pathways does not reduce the total number of pathways. Finally we have both graphical
output, containing heatmaps and topGO (optional) (Alexa and Rahnenfuhrer, 2010), and
spreadsheet output, containing p-value matrices of pathways and pathway clustering details
including gene composition and keywords.
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4.2.2 Meta-analytic pathway analysis
Compared with differentially-expressed gene analysis, pathway analysis gives more biologi-
cal insight and is more systematic and comprehensive. In CPI, we adopted method of over
representation analysis (ORA) when users input gene list and corresponding p-values from
each study. For users who preferred other types of pathway analysis, we also accepts lists of
significant pathways and the corresponding p-value as user input.. Given pathway enrich-
ment results, we perform Adaptively-weighted Fisher (AW Fisher) method (Li et al., 2011)
as meta-analysis, to identify pathways significant in one or more studies/conditions. AW
Fisher method not only increases the statistical power , but also gives a binary weight for
each pathway, indicating the significance of the pathway in each study/condition. Given a
user-specified q-value cutoff, we have a list of significant pathways, with some of them are
commonly significant across studies/conditions while some of them are significant in specific
study/condition.
4.2.3 Pathway clustering for reducing redundancy and enhancing interpretation
Because of the nature of pathways (e.g., hierarchy structure), many genes are shared among
different pathways. This redundancy often reduces the interpretability of the result from
pathway enrichment analysis. In CPI, we perform pathway clustering method to reduce the
redundancy among pathways. The similarity between different pathways is calculated based
on Kappa statistics, which depends on how many genes are mutual and exclusive among
those pathways. The kappa statistics represents the distance between two pathways based
on the genes composing each pathway. A distance matrix is then defined based 1-similarity
matrix, composing the distance between each pair of pathways. We provide options for users
to choose either consensus clustering or fuzzy cluster to perform the clustering analysis.
When consensus clustering is chosen in this step, follow the original consensus clustering
method, an elbow plot and consensus CDF plot are generated to help users decide the total
number of clusters
For most clustering algorithm including the consensus clustering we adopted, each path-
way will be forced to cluster into one group of pathways, no matter it’s scattered or not
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compared to the pathways within the same cluster. We allow scattered pathways to form
singletons, when its gene composition is different from other pathways, to avoid adding noise
to other existing clusters. To improve the tightness of the cluster, we further calculated the
silhouette width, a measure of how tightly each pathway is grouped in its cluster, and re-
moved the scattered pathways with low silhouette width. The removing cutoff for silhouette
width is estimated empirically based on its distribution from our multi-disease dataset. For
those singletons identified, we collect them into another cluster instead of filtering them out
because those pathways might be interesting in terms of unique genes composition.
4.2.4 Text mining for automated annotation of pathway clusters
4.2.4.1 Question description Reducing the redundancy of pathways by clustering per
se gives limited summary of the pathways. Since the user usually need to go through most of
the pathways in a cluster to grasp an idea and interpretation of the contents in the cluster,
the interpretation is not quantitative and largely rely on the biological knowledge of the user.
Therefore we need a more rigorous statistically meaningful representation and summary of
the cluster.
The above goal is expressed here as the text mining for key words for each clusters. So
the question becomes: which word appears more frequently in a certain cluster than they
usually would? We will therefore treat these words as the keywords for that cluster. The
key word is counted based on the number of pathways containing the word, rather than the
frequency of the word appearing in all pathways in a cluster.
4.2.4.2 Pathway-word matrix We first extracted the unique words in description and
term name of a pathway. Then we use R package Apache openNLP for tokenization, i.e.
identify nouns, adjectives, prepositions and etc. Plural nouns are combined with nouns,
words other than nouns and adjectives are filtered out because they are not informative
enough to be keywords of the cluster. The common English words and the words that are
found only in one pathway are filtered out for the same reason. Then we use R package
SnowballC to find word stems, so that the adjectives are combined with their corresponding
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nouns. The remaining is a binary matrix where each row being a word and each column
being a pathway, with element xij = 1 indicating that the pathway j contains the word i.
4.2.4.3 Test statistics A simple strategy to test for the significance of a word in a
cluster is by simple counting and conduct Fisher exact test. Yet we found this method to
be less powerful and biological justifiable from real data analysis, because the words in the
term name or a shorter description of a pathway are designed to be more representative
than those in a full or longer description. We therefore decide to penalize on words found in
longer description. We down-weighted the word count by assigning a score between 0 and 1
to each pathway j to indicate whether it contains word i:
xij =

1 word i appeared in term name of pathway j,
exp(−α|wj|) word i appeared only in description on pathway j,
0 otherwise
(4.2.1)
Where |wj| is the number of unique words in description of pathway j; α is a parameter
controlling the intensity of penalty. The greater the α is, the greater the penalty is on longer
description. When α equals to 0, there is no penalty and our test simplifies to is equivalent
to Fisher exact test.
And then we defined cluster score Ti(C) to be the sum of scores of pathways in the
cluster, i.e. for word i in a pathway cluster C, we have our test statistics:
Ti(C) =
∑
j∈C
xij
4.2.4.4 Permutation test To test for the null hypothesis that a word is not enriched
in a certain cluster, we adopt a permutation test. The basic argument of constructing the
permutation distribution for the test statistics, under the null hypothesis, is that all words
occur equally frequent across all clusters, including the unpermuted data. So for each word
i in the tth permutation, pathways are randomly sampled to form subset St with the same
cluster size as C. Test statistics Ti(St) is recomputed at the end of each permutation. The
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operation is then repeated for a large number of times (say, T times). At last, all Ti(St) are
ranked together with the original data Ti(C). And the p-value could be calculated thereby,
indicating how extremely frequent word i is seen in cluster C.
4.2.4.5 Graphical and Spreadsheet Output Suppose we already have the clustered
pathways and the AW Fisher p-value for each pathway, in this final step we aim to help users
understand the overall pattern of pathways significance better, by visualization approaches
including heatmaps of p-value for each pathway under each condition, heatmap of kappa
statistics for each pathway, and topGO graphs as an option if the input pathway database
contains GO.
4.2.4.6 Implementation CPI is implemented in R with packages, tools and novel meth-
ods mentioned above. A standalone R version of CPI is ideal for users with basic knowledge
of R and command line interface, and could take advantage of parallel computation on server.
A GUI version CPI is programmed with the help of R GUI project. This version of CPI can
be used by user of any level of programming proficiency while achieving the same results as
standalone R version.
4.2.4.7 Datasets and databases We provide 21 homo sapiens pathway database in-
cluding 14 pathway database from MsigDB, 2 database from Connectivity map, transcrip-
tion factor target database JASPAR, Protein-Protein interaction database and 3 microRNA
databases as options for enrichment analysis.
In addition, Gene Ontology, KEGG database for organism Mus musculus and Saccha-
romyces cerevisiae, JASPAR database for organism Mus musculus are provided.
4.3 RESULTS
4.3.0.1 Constructing the pathway-word matrix We first construct the pathway-
word matrix using the filtering steps described in methods section. Among the total 24302
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input pathways, we found 14251 unique words in term names and 34661 in full descriptions.
Pooling the words yields 36957 unique words in total. Starting from 36957 unique words,
we applied all filtering steps and trimmed the matrix down to 12949 unique words in 24302
pathways (Bird, 2006).
4.3.0.2 Justifying penalization in text mining Setting the text mining permutation
at 1000 times took a reasonable time for the whole analysis procedure: nine minutes. Our
results also demonstrate the power of penalized permutation test over Fisher’s exact test.
Since Fisher’s exact test treats words in description (can be up to 1500 words) the same as
words in pathway names (usually less than 15 words), signals of common biological words in
pathway names will be masked due to its high occurrence in pathway descriptions and some
non-informative words in descriptions will be detected as keywords falsely by chance. For
example, in our text mining results of the two tests, ”ATP” in the mitochondrial ATP activity
cluster was ranked low in the Fisher’s exact test (rank = 19) while prioritized in permutation
test (r=1). Some meaningless words such as ”buolo” and ”engelhardt” in a ribosome cluster
was ranked high by Fisher’s exact test (r = 4), but ranked low by penalized permutation test
(r = 34). To conclude, for detecting ordinary keyword, penalized permutation test performs
roughly the same as Fisher’s exact test, however, for detecting keyword of frequently occurred
biological vocabulary or filtering out strange jargons penalized permutation test is indeed
powerful than Fisher’s exact test.
4.3.0.3 Results for real data To demonstrate its utility, we applied CPI using the
default databases to analyze the transcriptome datasets of three psychiatric diseases of two
prefrontal cortex layers. These datasets, provided by Dr. David A. Lewis’ group, was used
previously to compare post-mortem tissue dorsolateral prefrontal cortex (DLPFC) layer 3
and layer 5 pyramidal cells’ gene expression level of bipolar disorder, major depressive and
schizophrenia patients with matched healthy control (Reinhart, 2015).
By inputting the top 400 differentially expressed genes in each of the six datasets and
default pathways containing 10 to 200 genes, top 100 major pathways of total 2187 pathways
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were identified and clustered to 7 clusters with 31 pathways as singleton terms. Of seven
clusters, three important clusters with insightful biological meaning are discussed below.
The elbow plot and consensus CDF plot (Figure 17ab) indicate that a cluster number of 7
is reasonable. Because when the number of clusters is greater than 7, the relative change in
area under CDF curve of elbow plot goes slows down (Figure 17a), and the consensus CDF
flattens out (Figure 17b).
Based on the heatmap output shown in Figure 19, we found that pathways in cluster 1
are significantly altered in schizophrenia DLPFC layer 5. Cluster 2, 5 and 7 shows similar
pattern, and are significantly enriched consensually in both schizophrenia DLPFC layer 3
and 5. Cluster 3 is enriched in the DLPFC layer 5 of two diseases: significantly in major
depression disorder, and marginally, bipolar disease. Cluster 4 is solely enriched in the layer
3 of schizophrenia. Cluster 6 is enriched significantly in layer 3 of schizophrenia, and slightly
in the layer 3 of schizophrenia and bipolar disease. And we also observed that the singletons
on the bottom of the heatmap display no consensual nor differential pattern, as they are
scattered pathways.
To further demonstrate the consensual and differential patterns of our results, we inspect
the contents of cluster 2, 3 and 6 with the help of text mining. The information provided
from these three pathways are diverse, even within a cluster. But those information could
be condensed statistically into keywords, with our penalized text mining method.
Cluster 2 consists of 8 pathways: KEGG Huntington’s disease, KEGG Alzheimer’s dis-
ease, Reactome Respiratory electron transport, ATP synthesis by chemiosmotic coupling,
and heat production by uncoupling proteins, Reactome Respiratory electron transport, Re-
actome The citric acid (TCA) cycle and respiratory electron transport, KEGG Parkinson’s
disease, KEGG Oxidative phosphorylation, KEGG Cardiac muscle contraction. Some of the
top keywords for cluster 2 under FDR cutoff 0.02 are: dysfunction, mitochondrial and ATP,
with word count 3, 5 and 3, respectively.
Cluster 3 consists of 10 pathways: BioCarta Role of Erk5 in Neuronal Survival, Bio-
Carta Human, Cytomegalovirus and Map Kinase Pathways, KEGG Fc epsilon RI signaling
pathway, KEGG Bladder cancer, KEGG Thyroid cancer, GO:MF MAP kinase activity, Re-
actome DSCAM interactions, Reactome Signalling to ERKs, Reactome Signalling to RAS,
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Reactome p38 MAPK events. The keywords under FDR cutoff 0.02 are: ERK2, MAPK and
MEK, with word count 3, 3 and 2, respectively.
Cluster 6 consists of 16 pathways. Manually inspected the pathways, we found this
cluster contains many ubiquitin-proteasome related genes. The text mining results consent
with that observation by giving top representative keywords under FDR cutoff 0.02 as:
proteasome, degradation and CDC6, with word count 3, 8 and 3, respectively.
4.4 DISCUSSION AND CONCLUSION
In this article, we explored the approaches for comparative meta-analytic pathway analysis,
and developed an integrative platform for this purpose called “CPI”. CPI reduces pathway
redundancy to condense knowledge discovered from the results and also conducts text min-
ing to provide statistically solid suggestions on interpreting results. Our method has three
advantages as compared to previous methods addressing pathway meta-analysis. First, CPI
explores consensual and differential expression pattern spontaneously in integrated pathway
analysis. Second, CPI clusters pathways by the gene composition to reduce pathway redun-
dancy. Third, CPI uses a statistically valid text mining method to interpret pathway analysis
results. In addition, the penalized text mining algorithm by permutation test has shown the
advantage over the standard test like Fisher’s exact test based on real data analysis. We
applied the tool to multiple psychiatric disorders transcriptomic data. The result identifies
multiple pathway enrichment patterns relevant to previously confirmed as well as novel bi-
ological functions, such as mitochondrial ATP dysfunction in schizophrenia DLPFC layer
3, ubiquitin-proteasome system dysregulation in schizophrenia and bipolar disorder DLPFC
layer 5 and altered MAPK/ERK signaling chain in major depression disorder DLPFC layer
5 (Arion et al., 2015).
CPI starts with input files that are either p-value matrices of gene from different studies,
or the Fisher p-value of significant pathways from each studies. Then CPI conduct meta
analysis using AW Fisher’s method to identify commonly and study-specific pathway enrich-
ment patterns. Consensus clustering is performed on the those significant pathways to reduce
pathway redundancy. And in the end, text mining is performed for the pathway clusters to
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automate the interpretation, extracted the keywords that could be otherwise overlooked in
either manual inspection of the results, or a more naive text mining method, for instance,
Fisher exact test. An example in our data is that, in pathway cluster 2 relating to mitochon-
drial ATP dysfunction, the keyword ATP is ranked by Fisher’s exact test as 19 and thus
ignored (when we only inspect top 10 significant keywords), but is prioritized to top 1 by
our penalized text mining method. In the end of CPI, the output heatmap and spreadsheet
containing significant pathway clusters, enrichment pattern, as well as the top significant
keywords representing the content of each pathway cluster are presented as results in each
CPI run.
We applied CPI to transcriptome datasets of three psychiatric diseases of two prefrontal
cortex layers from Dr. David A. Lewis’ lab. Analyzing the top 100 major pathways,our
results found that the MAPK/ERK signaling chain was altered in major depressive disorder
DLPFC layer 5 but not in layer 3. Reduced MAPK/ERK signaling in hippocampal area
is associated with depressive behavior. It is unknown whether major depressive disorder is
associated with altered MAPK/ERK signaling in dorsolateral prefrontal cortex. Our study
demonstrated altered MAPK/ERK signaling in major depressive disorder DLPFC layer 5
but not in layer 3 or the other two diseases.It remains an open question how this alteration
relates to major depression disorder symptoms. We also found that mitochondrial ATP dys-
function in DLPFC layer 3 and to a less extent in layer 5 of schizophrenia subjects, which is
consistent with a previous transcriptomic study of schizophrenia and schizoaffective disorder
in Dr. Lewis’ lab. And our results further indicated that the difference in the degree of
mitochondrial dysfunction across DLPFC layer 3 and layer 5 was due to different degrees of
mitochondrial ATP dysfunction rather than other aspects of mitochondrial dysfunction. An-
other previous finding from Dr. Lewis’s lab which associated ubiquitin-proteasome related
genes to schizophrenia layer 5 is also validated by CPI. Furthermore, consensual results across
different diseases and layers are shown by the significant alteration of ubiquitin-proteasome
system not only in schizophrenia DLPFC layer 5, but also in schizophrenia and bipolar
disorder DLPFC layer 3. Similar result from a blood based microarray investigation evi-
denced preliminarily ubiquitin-proteasome dysregulation in both schizophrenia and bipolar
disorder. However, the DE genes contributing to ubiquitin-proteasome dysregulation are dif-
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ferent in bipolar disorder and schizophrenia, which may need further biological investigation
and interpretation.
CPI has three major steps. In the first step, users may input either p-value matrix of
either genes or pathways for each study to start with. If p-values of genes are inputted, path-
way analysis is applied first. Then user may select a q-value cutoff for significant pathways
(Benjamini and Hochberg, 1995). And those pathways are passed down to meta analysis
where AW Fisher is applied to discover consensually and differentially enriched pathways.
We suggest 0.2 as our default cutoff, and the users may also choose their own cutoff according
to their budget on the follow-up experiments and analysis. We suggest aˆas as our default
cut-off, users can choose their own value according to different scenario. In the second step,
the pathways are clustered using consensus clustering, with consensus CDF plot and elbow
plot assisting users to choose the number of clusters (Monti et al., 2003). By default, a group
of six clusters were assessed. Silhouette information is used to achieve cluster tightness by
moving scattered pathways to singleton. The cutoff of 0.1 is selected using silhouette in-
formation (Rousseeuw, 1987) distribution from our multi-disease dataset, and results in a
reasonable number of singletons (30 out of 100 pathways). In the third step, text mining,
users may choose number of permutation iterations based on user’s computation capacity
and data size. The computational complexities of the CPI R standalone and GUI version are
similar. Using one thread on iX windows system, with the input of 6 gene lists with total of
84 subjects and 44k genes and the default pathway reference database, setting permutation
test iteration to be 1000, one run of CPI takes 9 minutes. Moreover, both versions can be
executed in parallel to further speed up the analysis.
CPI has several limitations. Firstly, for single study pathway analysis, our tool only
allows user to apply Fisher exact test, but it can be readily extend to include other methods
such as KS test and GSEA (Subramanian, 2005). Secondly, our text mining algorithm rely
on the descriptions provided by pathway databases. So for those pathway databases that
do not provide descriptions, e.g. some pathways in KEGG, text mining algorithm loses
advantages. Thirdly, computation time is not ignorable, especially in text mining step. For
the real data we applied, each 1000 permutation iterations increase 5 minutes computation
time.
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In summary, CPI is a meta-analytic tool for discovering commonly expressed and study
specific pattern in transcriptomic studies, that will also reduce pathway redundancy and
conduct text mining to increase interpretability of the results. CPI is implemented in R, as
well as RGUI, an R based graphical user interface. The RGUI version can be easily handled
by users without programming knowledge.
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Figure 16: The workflow of CPI
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Figure 17: Plots used to assist decision on total cluster number.
(a) Elbow plot. (b) Consensus CDF plot.
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Figure 18: Heatmap of logged p-value of pathways for all clusters using four additional
databases.
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Figure 19: Heatmap of logged p-value of pathways for all clusters using default databases.
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5.0 DISCUSSIONS AND FUTURE WORKS
5.1 DISCUSSION
The first paper proposed a Bayesian hierarchical model for multi-omics integration with
missingness. With the modern computational technologies and algorithms, for example,
MCMC Gibbs sampling and spike-and-slab priors, the construction and solution of complex
Bayesian hierarchical model became feasible and popular. Especially when integrating het-
erogeneous data types like multiple omics data, Bayesian hierarchical model is promising
in discovering the association between data types and selecting data-specific features. Our
model takes advantage of this feature, and further incorporates missing data handling and
self-paced learning decision making assistance.
The second paper proposed a novel computational algorithm to leverage both LD and
IBD information to enhance genotype imputation. Both LD and IBD information have been
proved to be a powerful in increasing genotyping accuracy. However, our method is the first
to incorporate both information in one model, and provide fast and stable solution by its
realization in hidden Markov model.
The third paper presented a meta-analytic pathway enrichment analysis framework. By
applying AW-Fisher’s method, pathway clustering, developing a text mining algorithm, and
etc., this framework have several merits compared to currently available methods, includ-
ing discovering differential and consensual pathways across studies simultaneously, reducing
pathway redundancies and using text mining algorithm to facilitate scientists in discovering
findings with more solid statistical support.
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5.2 FUTURE WORKS
For the Bayesian multi-omics integration project, after the resubmission of the paper, I
will consider using negative binomial distribution to better accommodate RNAseq gene ex-
pression count data when Gaussian assumption is violated. Futuremore, the model can be
extended to new types of omics data, for instance, single cell sequencing (scRNASeq) data.
And lastly, I will the statistical modeling under more complex missing patterns under missing
not at random assumption.
Google Brain Team (DePristo and Poplin, 2017) recently proposed a deep neural net-
work pipeline named DeepVariant for high-throughput sequencing data analysis. It’s variant
calling function could be a potential competitor to our LDIV method proposed in the second
paper. In addition, although tested in real data simulation, the method in second paper also
need to be used in real studies to support its performances.
Furthermore, I am also open to explore and analyze new high-throughput data types
in bioinformatics, and integrating them with currently available data types. In addition, I
am interested in developing statistical and computational genomics methods and software to
address pathology questions in cancer and complex disease studies. Lastly, I am interested
to serve for bridging recent advances in computer science and machine learning with clinical
and biological realms.
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APPENDIX A
APPENDIX FOR MULTI-OMICS BAYESIAN MODEL WITH
MISSINGNESS
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A.1 SUPPLEMENTARY MATERIALS
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Figure 20: ROC curves for feature selection comparisons for Scenario II and III.
a-b) are the ROC curves for feature selection comparison for Scenario II and III following
Figure 3. Scenario II: α = 0, β 6= 0, Scenario III: α 6= 0, β 6= 0. Star on each ROC curve is
the point with maximum Youden index.
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Figure 21: Manhattan plot for pathway analysis.
a) Manhattan plot for pathway analysis with full asthma dataset. b) Manhattan plot for
pathway analysis with 50% samples missing gene expressions. c) Manhattan plot for pathway
analysis with 50% samples missing methylation. d) Manhattan plot for pathway analysis
with 20% samples missing gene expressions and 20% samples missing methylation, but no
sample miss both gene expression and methylation at the same time.
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Figure 22: Pathway analysis similarity for pathway ordered by p-value.
X-axis is top 50 pathway index ordered by p-value from full data; y-axis is −log10(p) value
of CC in red versus FBMG (Scenario I and Scenario III) or FBMM (Scenario II).
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A.2 NON-INFORMATIVE PRIOR STRUCTURES AND MCMC GIBBS
SAMPLER
A.2.1 Non-informative prior structures
We use D = {Y,Mobs,Gobs,C} to denote the fully observed data, M = {γM , γM , γC ,Ω, σ,
σk,Gmis,Mmis, τ
M
k , τ
M
k , τ
ω
j , I
M
k , I
M
k , I
ω
j , pi
M , piM , piω} to denote the full parameter sets, among
which we are interested in γM , γM , γC ,Ω}. The full Bayesian Hierarchical model can be
generally written as:
P (M|D) ∝ P (M)P (D|M)
We starting laying out our prior constructions with our full Bayesian model (with GM
equivalently substituted by G−MΩ):
[Y |C,G,M;M] = CγC + (MΩ)γM + (G−MΩ)γM + 
[gk|·] = MJkωk + gMk ,gMk ∼MNN(0, σ2kIN×N)
 ∼MNN(0, σ2IN×N)
where Jk is the set of all mj0 within the promoter of kth gene, and J is the length of Jk.
Priors on other parameters are relatively straightforward:
[
γC
] ∼MNL(0, 106IL×L)
A.2.2 MCMC Gibbs sampler
From the full Bayesian hierarchical model in prior section:
P (M|D) ∝ P (M)P (D|M)
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P (M|D) is the posterior probability, P (M) is the prior, and P (D|M) is the likelihood. The
above can be written out as:
P (M|D)∝P (Y|gobs,k,gmis,k,C,M,Ω, γC , γMk , γMk , σ2)× P (gobs,k|Mobs,Ω, σ2k)
×P (gmis,k|Mmis,Ω, σ2k)× P (γMk |IMk , τMk )× P (γMk |IMk , τMk )× P (Ω|Iωj , τωj )
×P (IMk |piM)× P (IMk |piM)× P (Iωj |piω)× P (γC)× P ((τMk )2)× P ((τMk )2)
×P ((τωk )2)× P (piM)× P (piM)× P (piω)× P (σ2)× P (σ2k)× P ((σm)2)
We use MCMC Gibbs sampling as the approach to infer all posterior distributions. Some
of the Gibb’s samplers are listed below
• The effect of the j0th methylation level on the mRNA level of kth gene:
[ωj0,k|·] ∼ N(σ2n(Aσ−2k +B(γMk − γMk )σ−2)′mj0 , σ2n)
where A = (gk −MJk−j0ω−j0,k); B = (Y −CγC −GγM + M−j0ω−j0(γM − γM)); σ2n =
(σωj0
−2 +(σ−2k +σ
−2(γMk −γMk )2)m′j0mj0)−1. For k = 1, ..., K, and j0 ∈ Jk, which a the set
of all mj0 within the promoter of kth gene. mJk = (mj,j∈Jk), and m−j0 = (mj,j∈Jk,j 6=j0);
and similarly, ωJk,k = (ωj,k,j∈Jk), ω−j0,k = ωj,k,j∈Jk,j 6=j0
• The random error from the expression of gene k0 that is NOT explained by methylation:
[
σ2k|·
] ∼ Inv.Gamma(N
2
+ δ,
1
2
(gMk )
′(gMk ) + δ)
where this δ is a very small number originating from the Jeffery prior we put on σ2k
• The clinical effect:
[
γCl |·
] ∼ N(C′l(Y−MΩγM−(G−MΩ)γM−CγC−l)(σ2σ−20 +C′lCl)−1, (σ−2C′lCl+10−6)−1)
• All Gibbs samplers for γ′s takes similar forms but different components. The effects of
gene expression modulated by methylation, γM , is sampled from:
[
γMk |IMk = 1, (τM)2·
] ∼ N((MJkωk)′Aσ2n, σ2n)
where A = (Y −M−JkΩ−kγM − (G−MΩ)γM −CγC); and σ2n = (σ2(τM)−2 +
(MJkωk)
′MJkωk)
−1.
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• The effects of gene expression not modulated by methylation, γM , is sampled from:
[
γMk |IMk = 1, (τM)2·
]
∼ N(gMk ′Aσ2n, σ2n)
where A = (Y −MΩγM −GM−kγM−k −CγC); σ2n = (σ2(τM)−2 + gMk ′gMk )−1.
• The feature selection indicator for gene expression modulated by methylation IMk and its
corresponding hyper prior piM :
[
IMk |γMk , piM
] ∼ Bernoulli( piMk f(γMk |IMk = 1)
f(γMk |IMk = 0)(1− piM) + f(γMk |IMk = 1)piM
)
[
piM |IMk
] ∼ Beta(1 +∑
k
IMk , 1 +K −
∑
k
IMk )
• The feature selection indicator for gene expression not modulated by methylation IMk
and its corresponding hyper prior piM :
[
IMk |γMk , piM
]
∼ Bernoulli( pi
M
k f(γ
M
k |IMk = 1)
f(γMk |IMk = 0)(1− piM) + f(γMk |IMk = 1)piM
)
[
piM |IMk
]
∼ Beta(1 +
∑
k
IMk , 1 +K −
∑
k
IMk )
• The feature selection indicator for effect of methylation j on gene k, Iωk and its corre-
sponding hyper prior piω:
[
Iωj |γωj , piω
] ∼ Bernoulli( piωj f(γωj |Iωj = 1)
f(γωj |Iωj = 0)(1− piω) + f(γωj |Iωj = 1)piω
)
[
piω|Iωj
] ∼ Beta(1 +∑
j
Iωj , 1 + J −
∑
j
Iωj )
• The error term in clinical model is:
[
σ2|·] ∼ IG(N
2
+ δ,
1
2
A′A+ δ)
where A = Y − (G−MΩ)γM −MΩγM −CγC .
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• The variance (τM)2, (τM)2, (τω)2 in spike-slab prior are sampled from:
[
(τM)2|·] ∼ IG(1
2
K∑
k=1
IMk + δ,
1
2
K∑
k=1
(γMk )
2IMk + δ)
[
(τM)2|·
]
∼ IG(1
2
K∑
k=1
IMk + δ,
1
2
K∑
k=1
(γMk )
2IMk + δ)
[
(τω)2|·] ∼ IG(1
2
J∑
j=1
Iωj + δ,
1
2
J∑
j=1
(γωj )
2Iωj + δ)
Assuming missing in omics data, according to previous imputation model and corre-
sponding prior structure, the posterior distributions of the missing omics data are:
• First, in missing gene expression imputation, for the initial MCMC iteration, for b =
2, ....B iteration, the samples with missing gene expression are imputated as:
[gmis,j|·] ∼ MNNGmis(σ2n(AγMk σ−2 +Bσ−2k ), σ2n)
where σ2n = (σ
−2
k + σ
−2(γMk )
2)−1; A = (YNGmis − CNGmisγC − MNGmisΩ(γM − γM) −
Gmis,−kγM−k); B = (MNGmis,Jk ωk). Gmis,−k = Gmis,i where i ∈ (1...K), i 6= k.
Then the complete methylation level is simply:
gj = (g
′
obs,k,g
′
mis,k)
′
• Then, in missing methylation imputation, for the initial MCMC iteration, for b = 2, ....B
iteration, the samples with missing methylation level are imputated as:
[mmis,j|·] ∼ MVNNMmis×NMmis(σ2nωj,k(A(γMk − γMk )σ−2 +Bσ−2k ), σ2nINMmis×NMmis)
where σ2n = (1+ω
2
j,k(σ
−2
k +σ
−2(γMk −γMk )2))−1; A = (YNMmis−CNMmisγC−Mmis,−jΩ−j(γM−
γM)−GNMmisγM); B = (gNMmis,k−mmis,−jω−j,k). And mmis,−j = mmis,i where i ∈ Jk, i 6=
j, Mmis,−j = Mmis,i where i ∈ (1...J), i 6= j, Ω−j = Ωi where i ∈ (1...J), i 6= j.
Then the complete methylation level is simply:
mj = (m
′
obs,j,m
′
mis,j)
′
Now that all the conditional probabilities are obtained, one may use Gibbs sampling to
draw the posterior samples for the parameters following a certain sequence.
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APPENDIX B
APPENDIX FOR LDIV IMPROVED GENOTYPE CALLING IN
FAMLIY-BASED SEQUENCING DATA
B.1 SUPPLEMENTARY MATERIALS
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Figure 23: The overall genotyping accuracy for nuclear family type 3.
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Figure 24: The genotyping accuracy on heterozygote sites for nuclear family type 3.
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Figure 25: The genotyping accuracy on heterozygotes sites by MAF for nuclear family type
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Table 8: Overall genotyping accuracies for family type 3
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.9882 0.9874 0.9934 0.9522 0.9876 0.9952
2X BE30 0.9907 0.9896 0.9942 0.9525 0.9897 0.9953
6X BE20 0.9982 0.9986 0.9986 0.9966 0.999 0.9989
6X BE30 0.9984 0.9991 0.9993 0.9976 0.9994 0.9995
10X BE20 0.9993 0.9997 0.9997 0.9995 0.9998 0.9998
10X BE30 0.9995 0.9998 0.9998 0.9997 0.9999 0.9999
Table 9: Genotyping accuracies for heterozygote sites, family type 3
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.9444 0.948 0.9797 0.8145 0.9479 0.9819
2X BE30 0.9574 0.9586 0.9845 0.8232 0.9591 0.9847
6X BE20 0.9916 0.9931 0.9954 0.9853 0.995 0.9954
6X BE30 0.9926 0.9957 0.9976 0.9898 0.9973 0.9981
10X BE20 0.9968 0.9984 0.9991 0.9977 0.9989 0.9993
10X BE30 0.9979 0.999 0.9993 0.9985 0.9993 0.9994
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Table 10: Genotyping accuracies for rare heterozygote sites, family type 3
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.4287 0.442 0.6981 0.6596 0.6474 0.9009
2X BE30 0.5735 0.5826 0.6869 0.7449 0.7437 0.9178
6X BE20 0.8812 0.8633 0.89 0.9452 0.9448 0.9745
6X BE30 0.9343 0.9386 0.9687 0.9854 0.9859 0.9957
10X BE20 0.9608 0.9719 0.9839 0.9939 0.9939 0.9979
10X BE30 0.9804 0.9851 0.9951 0.9985 0.9985 0.9996
Table 11: Genotyping accuracies for moderate heterozygote sites, family type 3
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.8199 0.8316 0.9062 0.8387 0.8279 0.9315
2X BE30 0.8377 0.8208 0.9049 0.8845 0.8726 0.9297
6X BE20 0.989 0.9859 0.9787 0.9862 0.9858 0.9822
6X BE30 0.9867 0.9846 0.9869 0.9922 0.9925 0.9925
10X BE20 0.9961 0.9973 0.9965 0.9966 0.9969 0.9976
10X BE30 0.9972 0.9983 0.9976 0.9982 0.9983 0.9979
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Table 12: Genotyping accuracies for common heterozygote sites, family type 3
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.9824 0.9843 0.9942 0.8211 0.9785 0.9947
2X BE30 0.9833 0.9857 0.9947 0.8226 0.9786 0.9942
6X BE20 0.9957 0.9989 0.9983 0.9871 0.9982 0.998
6X BE30 0.9949 0.9987 0.999 0.9899 0.9984 0.9989
10X BE20 0.9984 0.9996 0.9996 0.9981 0.9995 0.9996
10X BE30 0.9985 0.9995 0.9996 0.9986 0.9995 0.9996
Table 13: Mendelian error rates for family type 3
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 28.82 14.22 8.833 0 13.33 7.689
2X BE30 25 16.36 7.189 0 9.222 6.989
6X BE20 6.422 3.667 2.289 0 0.7111 1.844
6X BE30 6.411 1.878 1.078 0 0.4222 0.8222
10X BE20 2.456 1.078 0.5444 0 0.2889 0.3222
10X BE30 2 0.7889 0.4111 0 0.2111 0.2778
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Table 14: Phasing accuracy for family type 3
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.9882 0.9737 0.9917 0.8295 0.9591 0.9693
2X BE30 0.9907 0.9747 0.992 0.8373 0.9635 0.9662
6X BE20 0.9982 0.9964 0.9978 0.9615 0.9912 0.9712
6X BE30 0.9984 0.9959 0.9986 0.9551 0.9922 0.971
10X BE20 0.9993 0.9991 0.9994 0.9736 0.9972 0.9673
10X BE30 0.9995 0.9994 0.9994 0.9914 0.9992 0.9749
Table 15: Overall genotyping accuracies for family type 4
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.99 0.9869 0.9946 0.9622 0.9892 0.9959
2X BE30 0.992 0.9909 0.9958 0.9665 0.9909 0.9965
6X BE20 0.9985 0.9987 0.9992 0.9978 0.9993 0.9997
6X BE30 0.9987 0.9991 0.9994 0.9988 0.9995 0.9997
10X BE20 0.9994 0.9997 0.9998 0.9997 0.9999 0.9999
10X BE30 0.9995 0.9998 0.9998 0.9999 0.9999 0.9999
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Table 16: Genotyping accuracies for heterozygote sites, family type 4
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.9515 0.9436 0.984 0.8586 0.9552 0.9843
2X BE30 0.9616 0.9594 0.9891 0.8773 0.9619 0.9879
6X BE20 0.9943 0.9944 0.9974 0.9922 0.9974 0.9987
6X BE30 0.994 0.9956 0.9977 0.9957 0.998 0.9989
10X BE20 0.9972 0.9987 0.9992 0.9987 0.9994 0.9996
10X BE30 0.998 0.9992 0.9992 0.9996 0.9996 0.9996
Table 17: Genotyping accuracies for rare heterozygote sites, family type 4
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.3675 0.3874 0.6135 0.6377 0.6376 0.8983
2X BE30 0.5886 0.5827 0.7833 0.8069 0.7877 0.9491
6X BE20 0.8763 0.8609 0.9517 0.9751 0.9751 0.9919
6X BE30 0.9489 0.9312 0.9625 0.984 0.984 0.9977
10X BE20 0.9509 0.9672 0.9737 0.9885 0.9885 0.9917
10X BE30 0.9725 0.9842 0.9839 0.9995 0.9995 0.9995
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Table 18: Genotyping accuracies for moderate heterozygote sites, family type 4
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.8472 0.8165 0.9263 0.8751 0.8734 0.9293
2X BE30 0.8661 0.8627 0.9472 0.8976 0.8903 0.9467
6X BE20 0.9898 0.9834 0.986 0.9919 0.9921 0.9951
6X BE30 0.9902 0.9848 0.9871 0.9968 0.9967 0.9974
10X BE20 0.9959 0.9969 0.9974 0.9992 0.9992 0.9995
10X BE30 0.9972 0.9984 0.996 0.9995 0.9994 0.9991
Table 19: Genotyping accuracies for common heterozygote sites, family type 4
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.985 0.9814 0.9959 0.8654 0.9777 0.9955
2X BE30 0.9864 0.9851 0.996 0.8793 0.9793 0.9947
6X BE20 0.9967 0.9986 0.999 0.9927 0.9984 0.9993
6X BE30 0.9956 0.9987 0.9991 0.996 0.9985 0.9991
10X BE20 0.9986 0.9996 0.9997 0.999 0.9997 0.9998
10X BE30 0.9986 0.9997 0.9997 0.9996 0.9996 0.9996
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Table 20: Overall genotyping accuracies for family type 5
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.9916 0.9891 0.9926 0.9546 0.9898 0.9947
2X BE30 0.9933 0.9904 0.9955 0.9591 0.9911 0.9967
6X BE20 0.9985 0.9988 0.9992 0.9947 0.9989 0.9995
6X BE30 0.9987 0.999 0.9992 0.9967 0.9993 0.9995
10X BE20 0.9994 0.9997 0.9997 0.9988 0.9997 0.9998
10X BE30 0.9995 0.9998 0.9998 0.9994 0.9998 0.9999
Table 21: Genotyping accuracies for heterozygote sites, family type 5
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.955 0.948 0.9747 0.7993 0.9494 0.9773
2X BE30 0.9632 0.9532 0.9843 0.8057 0.9555 0.9855
6X BE20 0.993 0.9939 0.9969 0.9753 0.9943 0.9974
6X BE30 0.9933 0.9946 0.9968 0.9818 0.996 0.9975
10X BE20 0.9974 0.9985 0.9989 0.9947 0.9986 0.9992
10X BE30 0.9978 0.9989 0.9992 0.997 0.999 0.9993
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Table 22: Genotyping accuracies for rare heterozygote sites, family type 5
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.4024 0.414 0.5093 0.6381 0.6306 0.859
2X BE30 0.5763 0.5694 0.7177 0.7199 0.6971 0.9206
6X BE20 0.8761 0.8755 0.9004 0.9409 0.9409 0.9814
6X BE30 0.919 0.9128 0.9378 0.9604 0.9594 0.9863
10X BE20 0.9501 0.97 0.9815 0.9871 0.9871 0.9964
10X BE30 0.9743 0.983 0.984 0.993 0.9928 0.9958
Table 23: Genotyping accuracies for moderate heterozygote sites, family type 5
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.8627 0.8191 0.8476 0.8068 0.7809 0.8616
2X BE30 0.8879 0.843 0.9143 0.8559 0.8297 0.9182
6X BE20 0.9917 0.9826 0.986 0.9721 0.972 0.9877
6X BE30 0.9904 0.9864 0.9863 0.9872 0.9857 0.9892
10X BE20 0.9978 0.9961 0.995 0.9938 0.9943 0.9968
10X BE30 0.9981 0.9978 0.9973 0.9965 0.9966 0.9976
100
Table 24: Genotyping accuracies for common heterozygote sites, family type 5
Beagle4 FamLDCaller FamLDCaller ref Polymutt2 LDIV LDIV ref
2X BE20 0.9877 0.9839 0.9959 0.8055 0.983 0.9959
2X BE30 0.9873 0.981 0.9964 0.8038 0.9813 0.9967
6X BE20 0.9965 0.9987 0.9991 0.9769 0.9982 0.9991
6X BE30 0.9959 0.9985 0.9989 0.982 0.9984 0.999
10X BE20 0.9986 0.9996 0.9995 0.9951 0.9995 0.9995
10X BE30 0.9986 0.9996 0.9996 0.9973 0.9995 0.9997
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